id	sid	tid	token	lemma	pos
bjos-8641016	1	1	oral	oral	ADJ
bjos-8641016	1	2	sciences	sciences	PROPN
bjos-8641016	1	3	n3	n3	NOUN
bjos-8641016	1	4	original	original	ADJ
bjos-8641016	1	5	article	article	NOUN
bjos-8641016	1	6	braz	braz	PROPN
bjos-8641016	1	7	j	j	PROPN
bjos-8641016	1	8	oral	oral	PROPN
bjos-8641016	1	9	sci	sci	PROPN
bjos-8641016	1	10	.	.	PUNCT
bjos-8641016	2	1	july	july	PROPN
bjos-8641016	2	2	|	|	ADV
bjos-8641016	2	3	september	september	PROPN
bjos-8641016	2	4	2013	2013	NUM
bjos-8641016	2	5	volume	volume	NOUN
bjos-8641016	2	6	12	12	NUM
bjos-8641016	2	7	,	,	PUNCT
bjos-8641016	2	8	number	number	NOUN
bjos-8641016	2	9	3	3	NUM
bjos-8641016	2	10	profile	profile	NOUN
bjos-8641016	2	11	of	of	ADP
bjos-8641016	2	12	salivary	salivary	ADJ
bjos-8641016	2	13	gland	gland	NOUN
bjos-8641016	2	14	flow	flow	NOUN
bjos-8641016	2	15	dysfunctions	dysfunction	NOUN
bjos-8641016	2	16	in	in	ADP
bjos-8641016	2	17	patients	patient	NOUN
bjos-8641016	2	18	with	with	ADP
bjos-8641016	2	19	differentiated	differentiated	ADJ
bjos-8641016	2	20	thyroid	thyroid	NOUN
bjos-8641016	2	21	carcinoma	carcinoma	NOUN
bjos-8641016	2	22	submitted	submit	VERB
bjos-8641016	2	23	to	to	PART
bjos-8641016	2	24	radioiodine	radioiodine	VERB
bjos-8641016	2	25	therapy	therapy	NOUN
bjos-8641016	2	26	anna	anna	PROPN
bjos-8641016	2	27	clara	clara	PROPN
bjos-8641016	2	28	fontes	fontes	PROPN
bjos-8641016	2	29	vieira1	vieira1	PROPN
bjos-8641016	2	30	,	,	PUNCT
bjos-8641016	2	31	aline	aline	PROPN
bjos-8641016	2	32	sampaio	sampaio	PROPN
bjos-8641016	2	33	lima	lima	PROPN
bjos-8641016	2	34	rodrigues1	rodrigues1	PROPN
bjos-8641016	2	35	,	,	PUNCT
bjos-8641016	2	36	maria	maria	PROPN
bjos-8641016	2	37	carmen	carmen	PROPN
bjos-8641016	2	38	fontoura	fontoura	PROPN
bjos-8641016	2	39	nogueira	nogueira	PROPN
bjos-8641016	2	40	da	da	PROPN
bjos-8641016	2	41	cruz1,2	cruz1,2	PROPN
bjos-8641016	2	42	,	,	PUNCT
bjos-8641016	2	43	fernanda	fernanda	PROPN
bjos-8641016	2	44	ferreira	ferreira	PROPN
bjos-8641016	2	45	lopes1,2	lopes1,2	PROPN
bjos-8641016	2	46	1department	1department	PROPN
bjos-8641016	2	47	of	of	ADP
bjos-8641016	2	48	dentistry	dentistry	NOUN
bjos-8641016	2	49	,	,	PUNCT
bjos-8641016	2	50	dental	dental	ADJ
bjos-8641016	2	51	school	school	NOUN
bjos-8641016	2	52	,	,	PUNCT
bjos-8641016	2	53	federal	federal	ADJ
bjos-8641016	2	54	university	university	NOUN
bjos-8641016	2	55	of	of	ADP
bjos-8641016	2	56	maranhão	maranhão	PROPN
bjos-8641016	2	57	,	,	PUNCT
bjos-8641016	2	58	são	são	PROPN
bjos-8641016	2	59	luís	luís	PROPN
bjos-8641016	2	60	,	,	PUNCT
bjos-8641016	2	61	ma	ma	PROPN
bjos-8641016	2	62	,	,	PUNCT
bjos-8641016	2	63	brazil	brazil	PROPN
bjos-8641016	2	64	2oral	2oral	NUM
bjos-8641016	2	65	pathology	pathology	NOUN
bjos-8641016	2	66	department	department	NOUN
bjos-8641016	2	67	,	,	PUNCT
bjos-8641016	2	68	dental	dental	ADJ
bjos-8641016	2	69	school	school	NOUN
bjos-8641016	2	70	,	,	PUNCT
bjos-8641016	2	71	federal	federal	ADJ
bjos-8641016	2	72	university	university	NOUN
bjos-8641016	2	73	of	of	ADP
bjos-8641016	2	74	maranhão	maranhão	PROPN
bjos-8641016	2	75	,	,	PUNCT
bjos-8641016	2	76	são	são	PROPN
bjos-8641016	2	77	luís	luís	PROPN
bjos-8641016	2	78	,	,	PUNCT
bjos-8641016	2	79	ma	ma	PROPN
bjos-8641016	2	80	,	,	PUNCT
bjos-8641016	2	81	brazil	brazil	PROPN
bjos-8641016	2	82	correspondence	correspondence	NOUN
bjos-8641016	2	83	to	to	ADP
bjos-8641016	2	84	:	:	PUNCT
bjos-8641016	2	85	fernanda	fernanda	PROPN
bjos-8641016	2	86	ferreira	ferreira	PROPN
bjos-8641016	2	87	lopes	lopes	PROPN
bjos-8641016	2	88	avenida	avenida	PROPN
bjos-8641016	2	89	dos	do	VERB
bjos-8641016	2	90	portugueses	portugueses	PROPN
bjos-8641016	2	91	,	,	PUNCT
bjos-8641016	2	92	campus	campus	NOUN
bjos-8641016	2	93	do	do	AUX
bjos-8641016	2	94	bacanga	bacanga	NOUN
bjos-8641016	2	95	s	s	PROPN
bjos-8641016	2	96	/	/	SYM
bjos-8641016	2	97	n	n	CCONJ
bjos-8641016	2	98	,	,	PUNCT
bjos-8641016	2	99	cep	cep	VERB
bjos-8641016	2	100	:	:	PUNCT
bjos-8641016	2	101	65085	65085	NUM
bjos-8641016	2	102	-	-	SYM
bjos-8641016	2	103	580	580	NUM
bjos-8641016	2	104	prédio	prédio	PROPN
bjos-8641016	2	105	de	de	X
bjos-8641016	2	106	odontologia	odontologia	PROPN
bjos-8641016	2	107	,	,	PUNCT
bjos-8641016	2	108	programa	programa	NOUN
bjos-8641016	2	109	de	de	PROPN
bjos-8641016	2	110	pós	pós	PROPN
bjos-8641016	2	111	-	-	PUNCT
bjos-8641016	2	112	graduação	graduação	NOUN
bjos-8641016	2	113	,	,	PUNCT
bjos-8641016	2	114	são	são	PROPN
bjos-8641016	2	115	luís	luís	PROPN
bjos-8641016	2	116	,	,	PUNCT
bjos-8641016	2	117	ma	ma	PROPN
bjos-8641016	2	118	,	,	PUNCT
bjos-8641016	2	119	brasil	brasil	PROPN
bjos-8641016	2	120	phone	phone	NOUN
bjos-8641016	2	121	:	:	PUNCT
bjos-8641016	2	122	+55	+55	PROPN
bjos-8641016	2	123	98	98	NUM
bjos-8641016	2	124	99717343	99717343	NUM
bjos-8641016	2	125	e	e	NOUN
bjos-8641016	2	126	-	-	NOUN
bjos-8641016	2	127	mail	mail	NOUN
bjos-8641016	2	128	:	:	PUNCT
bjos-8641016	2	129	fernanda.f.lopes@bol.com.br	fernanda.f.lopes@bol.com.br	ADJ
bjos-8641016	2	130	abstract	abstract	ADJ
bjos-8641016	2	131	aim	aim	NOUN
bjos-8641016	2	132	:	:	PUNCT
bjos-8641016	2	133	to	to	PART
bjos-8641016	2	134	evaluate	evaluate	VERB
bjos-8641016	2	135	the	the	DET
bjos-8641016	2	136	effects	effect	NOUN
bjos-8641016	2	137	of	of	ADP
bjos-8641016	2	138	radioiodine	radioiodine	NOUN
bjos-8641016	2	139	therapy	therapy	NOUN
bjos-8641016	2	140	on	on	ADP
bjos-8641016	2	141	salivary	salivary	ADJ
bjos-8641016	2	142	flow	flow	NOUN
bjos-8641016	2	143	in	in	ADP
bjos-8641016	2	144	patients	patient	NOUN
bjos-8641016	2	145	with	with	ADP
bjos-8641016	2	146	differentiated	differentiated	ADJ
bjos-8641016	2	147	thyroid	thyroid	NOUN
bjos-8641016	2	148	cancer	cancer	NOUN
bjos-8641016	2	149	.	.	PUNCT
bjos-8641016	3	1	methods	method	NOUN
bjos-8641016	3	2	:	:	PUNCT
bjos-8641016	3	3	a	a	DET
bjos-8641016	3	4	sample	sample	NOUN
bjos-8641016	3	5	comprising	comprise	VERB
bjos-8641016	3	6	88	88	NUM
bjos-8641016	3	7	patients	patient	NOUN
bjos-8641016	3	8	submitted	submit	VERB
bjos-8641016	3	9	to	to	PART
bjos-8641016	3	10	ablation	ablation	NOUN
bjos-8641016	3	11	with	with	ADP
bjos-8641016	3	12	iodine	iodine	NOUN
bjos-8641016	3	13	131	131	NUM
bjos-8641016	3	14	was	be	AUX
bjos-8641016	3	15	included	include	VERB
bjos-8641016	3	16	in	in	ADP
bjos-8641016	3	17	the	the	DET
bjos-8641016	3	18	study	study	NOUN
bjos-8641016	3	19	.	.	PUNCT
bjos-8641016	4	1	the	the	DET
bjos-8641016	4	2	patients	patient	NOUN
bjos-8641016	4	3	were	be	AUX
bjos-8641016	4	4	submitted	submit	VERB
bjos-8641016	4	5	to	to	ADP
bjos-8641016	4	6	sialometry	sialometry	NOUN
bjos-8641016	4	7	and	and	CCONJ
bjos-8641016	4	8	evaluation	evaluation	NOUN
bjos-8641016	4	9	of	of	ADP
bjos-8641016	4	10	the	the	DET
bjos-8641016	4	11	presence	presence	NOUN
bjos-8641016	4	12	of	of	ADP
bjos-8641016	4	13	xerostomia	xerostomia	NOUN
bjos-8641016	4	14	before	before	ADV
bjos-8641016	4	15	,	,	PUNCT
bjos-8641016	4	16	10	10	NUM
bjos-8641016	4	17	days	day	NOUN
bjos-8641016	4	18	and	and	CCONJ
bjos-8641016	4	19	3	3	NUM
bjos-8641016	4	20	months	month	NOUN
bjos-8641016	4	21	after	after	ADP
bjos-8641016	4	22	radioiodine	radioiodine	NOUN
bjos-8641016	4	23	therapy	therapy	NOUN
bjos-8641016	4	24	.	.	PUNCT
bjos-8641016	5	1	results	result	NOUN
bjos-8641016	5	2	:	:	PUNCT
bjos-8641016	5	3	xerostomia	xerostomia	PROPN
bjos-8641016	5	4	was	be	AUX
bjos-8641016	5	5	observed	observe	VERB
bjos-8641016	5	6	in	in	ADP
bjos-8641016	5	7	36.4	36.4	NUM
bjos-8641016	5	8	%	%	NOUN
bjos-8641016	5	9	of	of	ADP
bjos-8641016	5	10	the	the	DET
bjos-8641016	5	11	patients	patient	NOUN
bjos-8641016	5	12	before	before	ADP
bjos-8641016	5	13	radioiodine	radioiodine	NOUN
bjos-8641016	5	14	therapy	therapy	NOUN
bjos-8641016	5	15	,	,	PUNCT
bjos-8641016	5	16	59.15	59.15	NUM
bjos-8641016	5	17	%	%	NOUN
bjos-8641016	5	18	at	at	ADP
bjos-8641016	5	19	10	10	NUM
bjos-8641016	5	20	days	day	NOUN
bjos-8641016	5	21	after	after	ADP
bjos-8641016	5	22	therapy	therapy	NOUN
bjos-8641016	5	23	,	,	PUNCT
bjos-8641016	5	24	and	and	CCONJ
bjos-8641016	5	25	25	25	NUM
bjos-8641016	5	26	%	%	NOUN
bjos-8641016	5	27	at	at	ADP
bjos-8641016	5	28	3	3	NUM
bjos-8641016	5	29	months	month	NOUN
bjos-8641016	5	30	after	after	ADP
bjos-8641016	5	31	therapy	therapy	NOUN
bjos-8641016	5	32	.	.	PUNCT
bjos-8641016	6	1	significant	significant	ADJ
bjos-8641016	6	2	differences	difference	NOUN
bjos-8641016	6	3	were	be	AUX
bjos-8641016	6	4	observed	observe	VERB
bjos-8641016	6	5	in	in	ADP
bjos-8641016	6	6	non	non	ADJ
bjos-8641016	6	7	-	-	ADJ
bjos-8641016	6	8	stimulated	stimulated	ADJ
bjos-8641016	6	9	salivary	salivary	ADJ
bjos-8641016	6	10	flow	flow	NOUN
bjos-8641016	6	11	rates	rate	NOUN
bjos-8641016	6	12	between	between	ADP
bjos-8641016	6	13	the	the	DET
bjos-8641016	6	14	second	second	ADJ
bjos-8641016	6	15	and	and	CCONJ
bjos-8641016	6	16	third	third	ADJ
bjos-8641016	6	17	evaluations	evaluation	NOUN
bjos-8641016	6	18	(	(	PUNCT
bjos-8641016	6	19	p<0.020	p<0.020	NOUN
bjos-8641016	6	20	)	)	PUNCT
bjos-8641016	6	21	and	and	CCONJ
bjos-8641016	6	22	in	in	ADP
bjos-8641016	6	23	stimulated	stimulated	ADJ
bjos-8641016	6	24	salivary	salivary	ADJ
bjos-8641016	6	25	flow	flow	NOUN
bjos-8641016	6	26	between	between	ADP
bjos-8641016	6	27	the	the	DET
bjos-8641016	6	28	first	first	ADJ
bjos-8641016	6	29	and	and	CCONJ
bjos-8641016	6	30	second	second	ADJ
bjos-8641016	6	31	evaluations	evaluation	NOUN
bjos-8641016	6	32	(	(	PUNCT
bjos-8641016	6	33	p<0.010	p<0.010	NOUN
bjos-8641016	6	34	)	)	PUNCT
bjos-8641016	6	35	.	.	PUNCT
bjos-8641016	7	1	conclusions	conclusion	NOUN
bjos-8641016	7	2	:	:	PUNCT
bjos-8641016	7	3	the	the	DET
bjos-8641016	7	4	results	result	NOUN
bjos-8641016	7	5	suggest	suggest	VERB
bjos-8641016	7	6	that	that	SCONJ
bjos-8641016	7	7	changes	change	NOUN
bjos-8641016	7	8	in	in	ADP
bjos-8641016	7	9	salivary	salivary	ADJ
bjos-8641016	7	10	flow	flow	NOUN
bjos-8641016	7	11	resulting	result	VERB
bjos-8641016	7	12	from	from	ADP
bjos-8641016	7	13	radioiodine	radioiodine	NOUN
bjos-8641016	7	14	therapy	therapy	NOUN
bjos-8641016	7	15	are	be	AUX
bjos-8641016	7	16	more	more	ADV
bjos-8641016	7	17	pronounced	pronounced	ADJ
bjos-8641016	7	18	during	during	ADP
bjos-8641016	7	19	the	the	DET
bjos-8641016	7	20	first	first	ADJ
bjos-8641016	7	21	weeks	week	NOUN
bjos-8641016	7	22	after	after	ADP
bjos-8641016	7	23	treatment	treatment	NOUN
bjos-8641016	7	24	and	and	CCONJ
bjos-8641016	7	25	seem	seem	VERB
bjos-8641016	7	26	to	to	PART
bjos-8641016	7	27	regress	regress	NOUN
bjos-8641016	7	28	after	after	ADP
bjos-8641016	7	29	3	3	NUM
bjos-8641016	7	30	months	month	NOUN
bjos-8641016	7	31	.	.	PUNCT
bjos-8641016	8	1	keywords	keyword	NOUN
bjos-8641016	8	2	:	:	PUNCT
bjos-8641016	8	3	thyroid	thyroid	NOUN
bjos-8641016	8	4	gland	gland	NOUN
bjos-8641016	8	5	tumors	tumor	NOUN
bjos-8641016	8	6	,	,	PUNCT
bjos-8641016	8	7	iodine	iodine	NOUN
bjos-8641016	8	8	radioisotopes	radioisotope	NOUN
bjos-8641016	8	9	,	,	PUNCT
bjos-8641016	8	10	salivary	salivary	ADJ
bjos-8641016	8	11	glands	gland	NOUN
bjos-8641016	8	12	,	,	PUNCT
bjos-8641016	8	13	saliva	saliva	NOUN
bjos-8641016	8	14	,	,	PUNCT
bjos-8641016	8	15	xerostomia	xerostomia	NOUN
bjos-8641016	8	16	,	,	PUNCT
bjos-8641016	8	17	hyposalivation	hyposalivation	PROPN
bjos-8641016	8	18	.	.	PUNCT
bjos-8641016	9	1	introduction	introduction	NOUN
bjos-8641016	9	2	differentiated	differentiate	VERB
bjos-8641016	9	3	thyroid	thyroid	NOUN
bjos-8641016	9	4	carcinoma	carcinoma	NOUN
bjos-8641016	9	5	is	be	AUX
bjos-8641016	9	6	a	a	DET
bjos-8641016	9	7	curable	curable	ADJ
bjos-8641016	9	8	tumor	tumor	NOUN
bjos-8641016	9	9	,	,	PUNCT
bjos-8641016	9	10	especially	especially	ADV
bjos-8641016	9	11	when	when	SCONJ
bjos-8641016	9	12	diagnosed	diagnose	VERB
bjos-8641016	9	13	early	early	ADV
bjos-8641016	9	14	.	.	PUNCT
bjos-8641016	10	1	the	the	DET
bjos-8641016	10	2	most	most	ADV
bjos-8641016	10	3	adequate	adequate	ADJ
bjos-8641016	10	4	treatment	treatment	NOUN
bjos-8641016	10	5	istotal	istotal	NOUN
bjos-8641016	10	6	thyroidectomy	thyroidectomy	NOUN
bjos-8641016	10	7	followed	follow	VERB
bjos-8641016	10	8	by	by	ADP
bjos-8641016	10	9	actinic	actinic	ADJ
bjos-8641016	10	10	ablation	ablation	NOUN
bjos-8641016	10	11	with	with	ADP
bjos-8641016	10	12	radioactive	radioactive	ADJ
bjos-8641016	10	13	iodine	iodine	NOUN
bjos-8641016	10	14	(	(	PUNCT
bjos-8641016	10	15	iodine	iodine	NOUN
bjos-8641016	10	16	131	131	NUM
bjos-8641016	10	17	)	)	PUNCT
bjos-8641016	10	18	and	and	CCONJ
bjos-8641016	10	19	has	have	VERB
bjos-8641016	10	20	a	a	DET
bjos-8641016	10	21	very	very	ADV
bjos-8641016	10	22	good	good	ADJ
bjos-8641016	10	23	prognosis	prognosis	NOUN
bjos-8641016	10	24	(	(	PUNCT
bjos-8641016	10	25	in	in	ADP
bjos-8641016	10	26	more	more	ADJ
bjos-8641016	10	27	than	than	ADP
bjos-8641016	10	28	80	80	NUM
bjos-8641016	10	29	%	%	NOUN
bjos-8641016	10	30	of	of	ADP
bjos-8641016	10	31	cases	case	NOUN
bjos-8641016	10	32	)	)	PUNCT
bjos-8641016	10	33	with	with	ADP
bjos-8641016	10	34	excellent	excellent	ADJ
bjos-8641016	10	35	long	long	ADJ
bjos-8641016	10	36	-	-	PUNCT
bjos-8641016	10	37	term	term	NOUN
bjos-8641016	10	38	survival	survival	NOUN
bjos-8641016	10	39	,	,	PUNCT
bjos-8641016	10	40	similar	similar	ADJ
bjos-8641016	10	41	to	to	ADP
bjos-8641016	10	42	that	that	PRON
bjos-8641016	10	43	of	of	ADP
bjos-8641016	10	44	the	the	DET
bjos-8641016	10	45	population	population	NOUN
bjos-8641016	10	46	that	that	PRON
bjos-8641016	10	47	never	never	ADV
bjos-8641016	10	48	had	have	VERB
bjos-8641016	10	49	cancer1	cancer1	NOUN
bjos-8641016	10	50	.	.	PUNCT
bjos-8641016	11	1	iodine	iodine	NOUN
bjos-8641016	11	2	131	131	NUM
bjos-8641016	11	3	is	be	AUX
bjos-8641016	11	4	taken	take	VERB
bjos-8641016	11	5	up	up	ADP
bjos-8641016	11	6	by	by	ADP
bjos-8641016	11	7	the	the	DET
bjos-8641016	11	8	thyroid	thyroid	NOUN
bjos-8641016	11	9	through	through	ADP
bjos-8641016	11	10	the	the	DET
bjos-8641016	11	11	sodium	sodium	NOUN
bjos-8641016	11	12	/	/	SYM
bjos-8641016	11	13	iodide	iodide	NOUN
bjos-8641016	11	14	symporter	symporter	NOUN
bjos-8641016	11	15	(	(	PUNCT
bjos-8641016	11	16	nis	nis	NOUN
bjos-8641016	11	17	)	)	PUNCT
bjos-8641016	11	18	,	,	PUNCT
bjos-8641016	11	19	a	a	DET
bjos-8641016	11	20	protein	protein	NOUN
bjos-8641016	11	21	that	that	PRON
bjos-8641016	11	22	is	be	AUX
bjos-8641016	11	23	also	also	ADV
bjos-8641016	11	24	expressed	express	VERB
bjos-8641016	11	25	in	in	ADP
bjos-8641016	11	26	other	other	ADJ
bjos-8641016	11	27	tissues	tissue	NOUN
bjos-8641016	11	28	such	such	ADJ
bjos-8641016	11	29	as	as	ADP
bjos-8641016	11	30	the	the	DET
bjos-8641016	11	31	salivary	salivary	ADJ
bjos-8641016	11	32	glands	gland	NOUN
bjos-8641016	11	33	,	,	PUNCT
bjos-8641016	11	34	stomach	stomach	NOUN
bjos-8641016	11	35	and	and	CCONJ
bjos-8641016	11	36	breast	breast	NOUN
bjos-8641016	11	37	.	.	PUNCT
bjos-8641016	12	1	as	as	ADP
bjos-8641016	12	2	a	a	DET
bjos-8641016	12	3	consequence	consequence	NOUN
bjos-8641016	12	4	,	,	PUNCT
bjos-8641016	12	5	iodine	iodine	NOUN
bjos-8641016	12	6	131	131	NUM
bjos-8641016	12	7	can	can	AUX
bjos-8641016	12	8	cause	cause	VERB
bjos-8641016	12	9	damage	damage	NOUN
bjos-8641016	12	10	to	to	ADP
bjos-8641016	12	11	these	these	DET
bjos-8641016	12	12	structures	structure	NOUN
bjos-8641016	12	13	since	since	SCONJ
bjos-8641016	12	14	it	it	PRON
bjos-8641016	12	15	is	be	AUX
bjos-8641016	12	16	absorbed	absorb	VERB
bjos-8641016	12	17	at	at	ADP
bjos-8641016	12	18	these	these	DET
bjos-8641016	12	19	sites	site	NOUN
bjos-8641016	12	20	after	after	ADP
bjos-8641016	12	21	administration	administration	NOUN
bjos-8641016	12	22	of	of	ADP
bjos-8641016	12	23	therapeutic	therapeutic	ADJ
bjos-8641016	12	24	doses2	doses2	NOUN
bjos-8641016	12	25	-	-	PUNCT
bjos-8641016	12	26	4	4	NUM
bjos-8641016	12	27	.	.	PUNCT
bjos-8641016	13	1	the	the	DET
bjos-8641016	13	2	beta	beta	ADJ
bjos-8641016	13	3	radiation	radiation	NOUN
bjos-8641016	13	4	of	of	ADP
bjos-8641016	13	5	iodine	iodine	NOUN
bjos-8641016	13	6	131	131	NUM
bjos-8641016	13	7	exerts	exert	VERB
bjos-8641016	13	8	cytotoxic	cytotoxic	ADJ
bjos-8641016	13	9	effects	effect	NOUN
bjos-8641016	13	10	on	on	ADP
bjos-8641016	13	11	the	the	DET
bjos-8641016	13	12	salivary	salivary	ADJ
bjos-8641016	13	13	glands	gland	NOUN
bjos-8641016	13	14	because	because	SCONJ
bjos-8641016	13	15	these	these	DET
bjos-8641016	13	16	organs	organ	NOUN
bjos-8641016	13	17	are	be	AUX
bjos-8641016	13	18	highly	highly	ADV
bjos-8641016	13	19	radiosensitive5	radiosensitive5	ADJ
bjos-8641016	13	20	.	.	PUNCT
bjos-8641016	14	1	all	all	DET
bjos-8641016	14	2	salivary	salivary	ADJ
bjos-8641016	14	3	glands	gland	NOUN
bjos-8641016	14	4	are	be	AUX
bjos-8641016	14	5	involved	involve	VERB
bjos-8641016	14	6	in	in	ADP
bjos-8641016	14	7	the	the	DET
bjos-8641016	14	8	transport	transport	NOUN
bjos-8641016	14	9	of	of	ADP
bjos-8641016	14	10	radioactive	radioactive	ADJ
bjos-8641016	14	11	iodine	iodine	NOUN
bjos-8641016	14	12	into	into	ADP
bjos-8641016	14	13	the	the	DET
bjos-8641016	14	14	saliva6	saliva6	PROPN
bjos-8641016	14	15	.	.	PUNCT
bjos-8641016	15	1	saliva	saliva	NOUN
bjos-8641016	15	2	is	be	AUX
bjos-8641016	15	3	essential	essential	ADJ
bjos-8641016	15	4	to	to	PART
bjos-8641016	15	5	maintain	maintain	VERB
bjos-8641016	15	6	adequate	adequate	ADJ
bjos-8641016	15	7	oral	oral	ADJ
bjos-8641016	15	8	functions	function	NOUN
bjos-8641016	15	9	such	such	ADJ
bjos-8641016	15	10	as	as	ADP
bjos-8641016	15	11	lubrication	lubrication	NOUN
bjos-8641016	15	12	,	,	PUNCT
bjos-8641016	15	13	chewing	chew	VERB
bjos-8641016	15	14	and	and	CCONJ
bjos-8641016	15	15	swallowing	swallowing	NOUN
bjos-8641016	15	16	,	,	PUNCT
bjos-8641016	15	17	speech	speech	NOUN
bjos-8641016	15	18	,	,	PUNCT
bjos-8641016	15	19	oral	oral	ADJ
bjos-8641016	15	20	ph	ph	ADJ
bjos-8641016	15	21	balance	balance	NOUN
bjos-8641016	15	22	,	,	PUNCT
bjos-8641016	15	23	taste	taste	VERB
bjos-8641016	15	24	perception	perception	NOUN
bjos-8641016	15	25	,	,	PUNCT
bjos-8641016	15	26	and	and	CCONJ
bjos-8641016	15	27	cleanliness	cleanliness	NOUN
bjos-8641016	15	28	.	.	PUNCT
bjos-8641016	16	1	quantitative	quantitative	ADJ
bjos-8641016	16	2	and	and	CCONJ
bjos-8641016	16	3	qualitative	qualitative	ADJ
bjos-8641016	16	4	changes	change	NOUN
bjos-8641016	16	5	in	in	ADP
bjos-8641016	16	6	salivary	salivary	ADJ
bjos-8641016	16	7	flow	flow	NOUN
bjos-8641016	16	8	can	can	AUX
bjos-8641016	16	9	compromise	compromise	VERB
bjos-8641016	16	10	these	these	DET
bjos-8641016	16	11	functions	function	NOUN
bjos-8641016	16	12	.	.	PUNCT
bjos-8641016	17	1	consequently	consequently	ADV
bjos-8641016	17	2	,	,	PUNCT
bjos-8641016	17	3	subjects	subject	NOUN
bjos-8641016	17	4	with	with	ADP
bjos-8641016	17	5	salivary	salivary	ADJ
bjos-8641016	17	6	gland	gland	NOUN
bjos-8641016	17	7	dysfunction	dysfunction	NOUN
bjos-8641016	17	8	are	be	AUX
bjos-8641016	17	9	more	more	ADV
bjos-8641016	17	10	susceptible	susceptible	ADJ
bjos-8641016	17	11	to	to	ADP
bjos-8641016	17	12	periodontal	periodontal	ADJ
bjos-8641016	17	13	disease	disease	NOUN
bjos-8641016	17	14	,	,	PUNCT
bjos-8641016	17	15	rampant	rampant	ADJ
bjos-8641016	17	16	caries	carie	NOUN
bjos-8641016	17	17	,	,	PUNCT
bjos-8641016	17	18	and	and	CCONJ
bjos-8641016	17	19	fungal	fungal	ADJ
bjos-8641016	17	20	and	and	CCONJ
bjos-8641016	17	21	bacterial	bacterial	ADJ
bjos-8641016	17	22	oral	oral	NOUN
bjos-8641016	17	23	received	receive	VERB
bjos-8641016	17	24	for	for	ADP
bjos-8641016	17	25	publication	publication	NOUN
bjos-8641016	17	26	:	:	PUNCT
bjos-8641016	17	27	april	april	PROPN
bjos-8641016	17	28	30	30	NUM
bjos-8641016	17	29	,	,	PUNCT
bjos-8641016	17	30	2013	2013	NUM
bjos-8641016	17	31	accepted	accept	VERB
bjos-8641016	17	32	:	:	PUNCT
bjos-8641016	17	33	july	july	PROPN
bjos-8641016	17	34	31	31	NUM
bjos-8641016	17	35	,	,	PUNCT
bjos-8641016	17	36	2013	2013	NUM
bjos-8641016	17	37	braz	braz	PROPN
bjos-8641016	17	38	j	j	PROPN
bjos-8641016	17	39	oral	oral	PROPN
bjos-8641016	17	40	sci	sci	PROPN
bjos-8641016	17	41	.	.	PUNCT
bjos-8641016	18	1	12(3):169	12(3):169	NUM
bjos-8641016	18	2	-	-	SYM
bjos-8641016	18	3	172	172	NUM
bjos-8641016	18	4	170170170170170	170170170170170	NUM
bjos-8641016	18	5	infections7	infections7	NOUN
bjos-8641016	18	6	.	.	PUNCT
bjos-8641016	19	1	longitudinal	longitudinal	ADJ
bjos-8641016	19	2	studies	study	NOUN
bjos-8641016	19	3	investigating	investigate	VERB
bjos-8641016	19	4	the	the	DET
bjos-8641016	19	5	progression	progression	NOUN
bjos-8641016	19	6	and	and	CCONJ
bjos-8641016	19	7	intensity	intensity	NOUN
bjos-8641016	19	8	of	of	ADP
bjos-8641016	19	9	salivary	salivary	ADJ
bjos-8641016	19	10	gland	gland	NOUN
bjos-8641016	19	11	dysfunction	dysfunction	NOUN
bjos-8641016	19	12	in	in	ADP
bjos-8641016	19	13	patients	patient	NOUN
bjos-8641016	19	14	submitted	submit	VERB
bjos-8641016	19	15	to	to	PART
bjos-8641016	19	16	ablation	ablation	NOUN
bjos-8641016	19	17	with	with	ADP
bjos-8641016	19	18	iodine	iodine	NOUN
bjos-8641016	19	19	131	131	NUM
bjos-8641016	19	20	are	be	AUX
bjos-8641016	19	21	scarce	scarce	ADJ
bjos-8641016	19	22	in	in	ADP
bjos-8641016	19	23	the	the	DET
bjos-8641016	19	24	literature2,4,8	literature2,4,8	NOUN
bjos-8641016	19	25	-	-	SYM
bjos-8641016	19	26	9	9	NUM
bjos-8641016	19	27	.	.	PUNCT
bjos-8641016	20	1	the	the	DET
bjos-8641016	20	2	objective	objective	NOUN
bjos-8641016	20	3	of	of	ADP
bjos-8641016	20	4	the	the	DET
bjos-8641016	20	5	present	present	ADJ
bjos-8641016	20	6	study	study	NOUN
bjos-8641016	20	7	was	be	AUX
bjos-8641016	20	8	to	to	PART
bjos-8641016	20	9	evaluate	evaluate	VERB
bjos-8641016	20	10	the	the	DET
bjos-8641016	20	11	effects	effect	NOUN
bjos-8641016	20	12	of	of	ADP
bjos-8641016	20	13	iodine	iodine	NOUN
bjos-8641016	20	14	131	131	NUM
bjos-8641016	20	15	on	on	ADP
bjos-8641016	20	16	the	the	DET
bjos-8641016	20	17	salivary	salivary	ADJ
bjos-8641016	20	18	glands	gland	NOUN
bjos-8641016	20	19	by	by	ADP
bjos-8641016	20	20	subjective	subjective	ADJ
bjos-8641016	20	21	symptom	symptom	NOUN
bjos-8641016	20	22	of	of	ADP
bjos-8641016	20	23	dryness	dryness	NOUN
bjos-8641016	20	24	in	in	ADP
bjos-8641016	20	25	the	the	DET
bjos-8641016	20	26	mouth	mouth	NOUN
bjos-8641016	20	27	(	(	PUNCT
bjos-8641016	20	28	xerostomia	xerostomia	NOUN
bjos-8641016	20	29	)	)	PUNCT
bjos-8641016	20	30	and	and	CCONJ
bjos-8641016	20	31	reduced	reduce	VERB
bjos-8641016	20	32	salivary	salivary	ADJ
bjos-8641016	20	33	flow	flow	NOUN
bjos-8641016	20	34	(	(	PUNCT
bjos-8641016	20	35	hyposalivation	hyposalivation	NOUN
bjos-8641016	20	36	)	)	PUNCT
bjos-8641016	20	37	of	of	ADP
bjos-8641016	20	38	patients	patient	NOUN
bjos-8641016	20	39	with	with	ADP
bjos-8641016	20	40	differentiated	differentiated	ADJ
bjos-8641016	20	41	thyroid	thyroid	NOUN
bjos-8641016	20	42	carcinoma	carcinoma	NOUN
bjos-8641016	20	43	submitted	submit	VERB
bjos-8641016	20	44	to	to	PART
bjos-8641016	20	45	radioiodine	radioiodine	VERB
bjos-8641016	20	46	therapy	therapy	NOUN
bjos-8641016	20	47	.	.	PUNCT
bjos-8641016	21	1	xerostomia	xerostomia	PROPN
bjos-8641016	21	2	and	and	CCONJ
bjos-8641016	21	3	salivary	salivary	ADJ
bjos-8641016	21	4	flow	flow	NOUN
bjos-8641016	21	5	were	be	AUX
bjos-8641016	21	6	compared	compare	VERB
bjos-8641016	21	7	before	before	ADP
bjos-8641016	21	8	and	and	CCONJ
bjos-8641016	21	9	after	after	SCONJ
bjos-8641016	21	10	therapy	therapy	NOUN
bjos-8641016	21	11	to	to	PART
bjos-8641016	21	12	establish	establish	VERB
bjos-8641016	21	13	the	the	DET
bjos-8641016	21	14	progression	progression	NOUN
bjos-8641016	21	15	and	and	CCONJ
bjos-8641016	21	16	frequency	frequency	NOUN
bjos-8641016	21	17	of	of	ADP
bjos-8641016	21	18	salivary	salivary	ADJ
bjos-8641016	21	19	changes	change	NOUN
bjos-8641016	21	20	considering	consider	VERB
bjos-8641016	21	21	the	the	DET
bjos-8641016	21	22	high	high	ADJ
bjos-8641016	21	23	survival	survival	NOUN
bjos-8641016	21	24	rate	rate	NOUN
bjos-8641016	21	25	of	of	ADP
bjos-8641016	21	26	these	these	DET
bjos-8641016	21	27	patients	patient	NOUN
bjos-8641016	21	28	.	.	PUNCT
bjos-8641016	22	1	material	material	NOUN
bjos-8641016	22	2	and	and	CCONJ
bjos-8641016	22	3	methods	method	NOUN
bjos-8641016	22	4	a	a	DET
bjos-8641016	22	5	clinical	clinical	ADJ
bjos-8641016	22	6	longitudinal	longitudinal	ADJ
bjos-8641016	22	7	study	study	NOUN
bjos-8641016	22	8	with	with	ADP
bjos-8641016	22	9	of	of	ADP
bjos-8641016	22	10	88	88	NUM
bjos-8641016	22	11	patients	patient	NOUN
bjos-8641016	22	12	with	with	ADP
bjos-8641016	22	13	differentiated	differentiated	ADJ
bjos-8641016	22	14	thyroid	thyroid	NOUN
bjos-8641016	22	15	carcinoma	carcinoma	NOUN
bjos-8641016	22	16	(	(	PUNCT
bjos-8641016	22	17	papillary	papillary	ADJ
bjos-8641016	22	18	and	and	CCONJ
bjos-8641016	22	19	follicular	follicular	ADJ
bjos-8641016	22	20	)	)	PUNCT
bjos-8641016	22	21	who	who	PRON
bjos-8641016	22	22	underwent	undergo	VERB
bjos-8641016	22	23	complementary	complementary	ADJ
bjos-8641016	22	24	treatment	treatment	NOUN
bjos-8641016	22	25	with	with	ADP
bjos-8641016	22	26	high	high	ADJ
bjos-8641016	22	27	single	single	ADJ
bjos-8641016	22	28	doses	dose	NOUN
bjos-8641016	22	29	of	of	ADP
bjos-8641016	22	30	iodine	iodine	NOUN
bjos-8641016	22	31	131	131	NUM
bjos-8641016	22	32	(	(	PUNCT
bjos-8641016	22	33	100	100	NUM
bjos-8641016	22	34	to	to	PART
bjos-8641016	22	35	150	150	NUM
bjos-8641016	22	36	mci	mci	NOUN
bjos-8641016	22	37	)	)	PUNCT
bjos-8641016	22	38	.	.	PUNCT
bjos-8641016	23	1	the	the	DET
bjos-8641016	23	2	patients	patient	NOUN
bjos-8641016	23	3	were	be	AUX
bjos-8641016	23	4	treated	treat	VERB
bjos-8641016	23	5	at	at	ADP
bjos-8641016	23	6	the	the	DET
bjos-8641016	23	7	radioiodine	radioiodine	NOUN
bjos-8641016	23	8	therapy	therapy	NOUN
bjos-8641016	23	9	service	service	NOUN
bjos-8641016	23	10	of	of	ADP
bjos-8641016	23	11	instituto	instituto	PROPN
bjos-8641016	23	12	maranhense	maranhense	PROPN
bjos-8641016	23	13	de	de	PROPN
bjos-8641016	23	14	oncologia	oncologia	PROPN
bjos-8641016	23	15	aldenora	aldenora	PROPN
bjos-8641016	23	16	bello	bello	PROPN
bjos-8641016	23	17	and	and	CCONJ
bjos-8641016	23	18	had	have	AUX
bjos-8641016	23	19	not	not	PART
bjos-8641016	23	20	used	use	VERB
bjos-8641016	23	21	drugs	drug	NOUN
bjos-8641016	23	22	to	to	PART
bjos-8641016	23	23	treat	treat	VERB
bjos-8641016	23	24	other	other	ADJ
bjos-8641016	23	25	comorbidities	comorbiditie	NOUN
bjos-8641016	23	26	.	.	PUNCT
bjos-8641016	24	1	the	the	DET
bjos-8641016	24	2	collected	collect	VERB
bjos-8641016	24	3	data	datum	NOUN
bjos-8641016	24	4	were	be	AUX
bjos-8641016	24	5	:	:	PUNCT
bjos-8641016	24	6	personal	personal	ADJ
bjos-8641016	24	7	identification	identification	NOUN
bjos-8641016	24	8	(	(	PUNCT
bjos-8641016	24	9	name	name	NOUN
bjos-8641016	24	10	,	,	PUNCT
bjos-8641016	24	11	age	age	NOUN
bjos-8641016	24	12	,	,	PUNCT
bjos-8641016	24	13	gender	gender	NOUN
bjos-8641016	24	14	,	,	PUNCT
bjos-8641016	24	15	educational	educational	ADJ
bjos-8641016	24	16	level	level	NOUN
bjos-8641016	24	17	and	and	CCONJ
bjos-8641016	24	18	marital	marital	ADJ
bjos-8641016	24	19	status	status	NOUN
bjos-8641016	24	20	)	)	PUNCT
bjos-8641016	24	21	,	,	PUNCT
bjos-8641016	24	22	anatomopathological	anatomopathological	ADJ
bjos-8641016	24	23	definition	definition	NOUN
bjos-8641016	24	24	of	of	ADP
bjos-8641016	24	25	the	the	DET
bjos-8641016	24	26	tumor	tumor	NOUN
bjos-8641016	24	27	,	,	PUNCT
bjos-8641016	24	28	data	datum	NOUN
bjos-8641016	24	29	of	of	ADP
bjos-8641016	24	30	radioiodine	radioiodine	NOUN
bjos-8641016	24	31	therapy	therapy	NOUN
bjos-8641016	24	32	(	(	PUNCT
bjos-8641016	24	33	dose	dose	PROPN
bjos-8641016	24	34	)	)	PUNCT
bjos-8641016	24	35	,	,	PUNCT
bjos-8641016	24	36	presence	presence	NOUN
bjos-8641016	24	37	or	or	CCONJ
bjos-8641016	24	38	absence	absence	NOUN
bjos-8641016	24	39	of	of	ADP
bjos-8641016	24	40	xerostomia	xerostomia	NOUN
bjos-8641016	24	41	and	and	CCONJ
bjos-8641016	24	42	salivary	salivary	ADJ
bjos-8641016	24	43	flow	flow	NOUN
bjos-8641016	24	44	.	.	PUNCT
bjos-8641016	25	1	xerostomia	xerostomia	NOUN
bjos-8641016	25	2	and	and	CCONJ
bjos-8641016	25	3	salivary	salivary	ADJ
bjos-8641016	25	4	flow	flow	NOUN
bjos-8641016	25	5	were	be	AUX
bjos-8641016	25	6	evaluated	evaluate	VERB
bjos-8641016	25	7	at	at	ADP
bjos-8641016	25	8	three	three	NUM
bjos-8641016	25	9	time	time	NOUN
bjos-8641016	25	10	points	point	NOUN
bjos-8641016	25	11	:	:	PUNCT
bjos-8641016	25	12	before	before	SCONJ
bjos-8641016	25	13	radioiodine	radioiodine	NOUN
bjos-8641016	25	14	therapy	therapy	NOUN
bjos-8641016	25	15	,	,	PUNCT
bjos-8641016	25	16	10	10	NUM
bjos-8641016	25	17	days	day	NOUN
bjos-8641016	25	18	after	after	ADP
bjos-8641016	25	19	treatment	treatment	NOUN
bjos-8641016	25	20	(	(	PUNCT
bjos-8641016	25	21	when	when	SCONJ
bjos-8641016	25	22	a	a	DET
bjos-8641016	25	23	complete	complete	ADJ
bjos-8641016	25	24	body	body	NOUN
bjos-8641016	25	25	scanning	scanning	NOUN
bjos-8641016	25	26	for	for	ADP
bjos-8641016	25	27	the	the	DET
bjos-8641016	25	28	detection	detection	NOUN
bjos-8641016	25	29	of	of	ADP
bjos-8641016	25	30	metastases	metastasis	NOUN
bjos-8641016	25	31	was	be	AUX
bjos-8641016	25	32	done	do	VERB
bjos-8641016	25	33	)	)	PUNCT
bjos-8641016	25	34	,	,	PUNCT
bjos-8641016	25	35	and	and	CCONJ
bjos-8641016	25	36	after	after	ADP
bjos-8641016	25	37	3	3	NUM
bjos-8641016	25	38	months	month	NOUN
bjos-8641016	25	39	.	.	PUNCT
bjos-8641016	26	1	xerostomia	xerostomia	PROPN
bjos-8641016	26	2	was	be	AUX
bjos-8641016	26	3	evaluated	evaluate	VERB
bjos-8641016	26	4	by	by	ADP
bjos-8641016	26	5	subjective	subjective	ADJ
bjos-8641016	26	6	symptoms	symptom	NOUN
bjos-8641016	26	7	of	of	ADP
bjos-8641016	26	8	dryness	dryness	NOUN
bjos-8641016	26	9	in	in	ADP
bjos-8641016	26	10	the	the	DET
bjos-8641016	26	11	mouth	mouth	NOUN
bjos-8641016	26	12	during	during	ADP
bjos-8641016	26	13	anamnesis	anamnesis	NOUN
bjos-8641016	26	14	,	,	PUNCT
bjos-8641016	26	15	and	and	CCONJ
bjos-8641016	26	16	classified	classify	VERB
bjos-8641016	26	17	as	as	ADP
bjos-8641016	26	18	present	present	ADJ
bjos-8641016	26	19	or	or	CCONJ
bjos-8641016	26	20	absent	absent	ADJ
bjos-8641016	26	21	.	.	PUNCT
bjos-8641016	27	1	the	the	DET
bjos-8641016	27	2	patients	patient	NOUN
bjos-8641016	27	3	did	do	AUX
bjos-8641016	27	4	not	not	PART
bjos-8641016	27	5	receive	receive	VERB
bjos-8641016	27	6	any	any	DET
bjos-8641016	27	7	recommendation	recommendation	NOUN
bjos-8641016	27	8	for	for	ADP
bjos-8641016	27	9	home	home	NOUN
bjos-8641016	27	10	salivary	salivary	ADJ
bjos-8641016	27	11	gland	gland	NOUN
bjos-8641016	27	12	stimulation	stimulation	NOUN
bjos-8641016	27	13	,	,	PUNCT
bjos-8641016	27	14	during	during	ADP
bjos-8641016	27	15	the	the	DET
bjos-8641016	27	16	period	period	NOUN
bjos-8641016	27	17	of	of	ADP
bjos-8641016	27	18	this	this	DET
bjos-8641016	27	19	study	study	NOUN
bjos-8641016	27	20	.	.	PUNCT
bjos-8641016	28	1	stimulated	stimulate	VERB
bjos-8641016	28	2	and	and	CCONJ
bjos-8641016	28	3	non	non	ADJ
bjos-8641016	28	4	-	-	ADJ
bjos-8641016	28	5	stimulated	stimulated	ADJ
bjos-8641016	28	6	whole	whole	ADJ
bjos-8641016	28	7	saliva	saliva	NOUN
bjos-8641016	28	8	samples	sample	NOUN
bjos-8641016	28	9	were	be	AUX
bjos-8641016	28	10	collected	collect	VERB
bjos-8641016	28	11	for	for	ADP
bjos-8641016	28	12	analysis	analysis	NOUN
bjos-8641016	28	13	of	of	ADP
bjos-8641016	28	14	salivary	salivary	ADJ
bjos-8641016	28	15	flow10	flow10	NOUN
bjos-8641016	28	16	.	.	PUNCT
bjos-8641016	29	1	the	the	DET
bjos-8641016	29	2	patients	patient	NOUN
bjos-8641016	29	3	did	do	AUX
bjos-8641016	29	4	not	not	PART
bjos-8641016	29	5	drink	drink	VERB
bjos-8641016	29	6	or	or	CCONJ
bjos-8641016	29	7	eat	eat	VERB
bjos-8641016	29	8	90	90	NUM
bjos-8641016	29	9	min	min	NOUN
bjos-8641016	29	10	before	before	ADP
bjos-8641016	29	11	sialometry	sialometry	NOUN
bjos-8641016	29	12	.	.	PUNCT
bjos-8641016	30	1	all	all	DET
bjos-8641016	30	2	tests	test	NOUN
bjos-8641016	30	3	were	be	AUX
bjos-8641016	30	4	performed	perform	VERB
bjos-8641016	30	5	at	at	ADP
bjos-8641016	30	6	the	the	DET
bjos-8641016	30	7	same	same	ADJ
bjos-8641016	30	8	time	time	NOUN
bjos-8641016	30	9	(	(	PUNCT
bjos-8641016	30	10	13:00	13:00	NUM
bjos-8641016	30	11	to	to	PART
bjos-8641016	30	12	15:00	15:00	NUM
bjos-8641016	30	13	h	h	NOUN
bjos-8641016	30	14	)	)	PUNCT
bjos-8641016	30	15	to	to	PART
bjos-8641016	30	16	minimize	minimize	VERB
bjos-8641016	30	17	variations	variation	NOUN
bjos-8641016	30	18	in	in	ADP
bjos-8641016	30	19	salivary	salivary	ADJ
bjos-8641016	30	20	secretion11	secretion11	NOUN
bjos-8641016	30	21	.	.	PUNCT
bjos-8641016	31	1	descriptive	descriptive	ADJ
bjos-8641016	31	2	statistics	statistic	NOUN
bjos-8641016	31	3	was	be	AUX
bjos-8641016	31	4	used	use	VERB
bjos-8641016	31	5	for	for	ADP
bjos-8641016	31	6	analysis	analysis	NOUN
bjos-8641016	31	7	and	and	CCONJ
bjos-8641016	31	8	the	the	DET
bjos-8641016	31	9	results	result	NOUN
bjos-8641016	31	10	were	be	AUX
bjos-8641016	31	11	compared	compare	VERB
bjos-8641016	31	12	by	by	ADP
bjos-8641016	31	13	the	the	DET
bjos-8641016	31	14	paired	pair	VERB
bjos-8641016	31	15	student	student	NOUN
bjos-8641016	31	16	’s	’s	PART
bjos-8641016	31	17	t	t	PROPN
bjos-8641016	31	18	-	-	PUNCT
bjos-8641016	31	19	test	test	NOUN
bjos-8641016	31	20	,	,	PUNCT
bjos-8641016	31	21	adopting	adopt	VERB
bjos-8641016	31	22	a	a	DET
bjos-8641016	31	23	5	5	NUM
bjos-8641016	31	24	%	%	NOUN
bjos-8641016	31	25	significance	significance	NOUN
bjos-8641016	31	26	level	level	NOUN
bjos-8641016	31	27	.	.	PUNCT
bjos-8641016	32	1	the	the	DET
bjos-8641016	32	2	study	study	NOUN
bjos-8641016	32	3	was	be	AUX
bjos-8641016	32	4	approved	approve	VERB
bjos-8641016	32	5	by	by	ADP
bjos-8641016	32	6	the	the	DET
bjos-8641016	32	7	ethics	ethic	NOUN
bjos-8641016	32	8	committee	committee	PROPN
bjos-8641016	32	9	of	of	ADP
bjos-8641016	32	10	the	the	DET
bjos-8641016	32	11	federal	federal	ADJ
bjos-8641016	32	12	university	university	PROPN
bjos-8641016	32	13	of	of	ADP
bjos-8641016	32	14	maranhão	maranhão	PROPN
bjos-8641016	32	15	(	(	PUNCT
bjos-8641016	32	16	protocol	protocol	NOUN
bjos-8641016	32	17	23115005754/	23115005754/	NUM
bjos-8641016	32	18	2009	2009	NUM
bjos-8641016	32	19	-	-	SYM
bjos-8641016	32	20	00	00	NUM
bjos-8641016	32	21	)	)	PUNCT
bjos-8641016	32	22	and	and	CCONJ
bjos-8641016	32	23	all	all	DET
bjos-8641016	32	24	patients	patient	NOUN
bjos-8641016	32	25	signed	sign	VERB
bjos-8641016	32	26	an	an	DET
bjos-8641016	32	27	informed	informed	ADJ
bjos-8641016	32	28	consent	consent	NOUN
bjos-8641016	32	29	form	form	NOUN
bjos-8641016	32	30	.	.	PUNCT
bjos-8641016	33	1	results	result	NOUN
bjos-8641016	33	2	in	in	ADP
bjos-8641016	33	3	a	a	DET
bjos-8641016	33	4	convenience	convenience	NOUN
bjos-8641016	33	5	sample	sample	NOUN
bjos-8641016	33	6	of	of	ADP
bjos-8641016	33	7	88	88	NUM
bjos-8641016	33	8	patients	patient	NOUN
bjos-8641016	33	9	submitted	submit	VERB
bjos-8641016	33	10	to	to	PART
bjos-8641016	33	11	ablation	ablation	NOUN
bjos-8641016	33	12	with	with	ADP
bjos-8641016	33	13	iodine	iodine	NOUN
bjos-8641016	33	14	131	131	NUM
bjos-8641016	33	15	,	,	PUNCT
bjos-8641016	33	16	differentiated	differentiated	ADJ
bjos-8641016	33	17	thyroid	thyroid	NOUN
bjos-8641016	33	18	carcinoma	carcinoma	NOUN
bjos-8641016	33	19	was	be	AUX
bjos-8641016	33	20	more	more	ADV
bjos-8641016	33	21	prevalent	prevalent	ADJ
bjos-8641016	33	22	among	among	ADP
bjos-8641016	33	23	women	woman	NOUN
bjos-8641016	33	24	(	(	PUNCT
bjos-8641016	33	25	n=80	n=80	PROPN
bjos-8641016	33	26	)	)	PUNCT
bjos-8641016	33	27	than	than	ADP
bjos-8641016	33	28	men	man	NOUN
bjos-8641016	33	29	(	(	PUNCT
bjos-8641016	33	30	n=8	n=8	NUM
bjos-8641016	33	31	)	)	PUNCT
bjos-8641016	33	32	.	.	PUNCT
bjos-8641016	34	1	patient	patient	ADJ
bjos-8641016	34	2	age	age	NOUN
bjos-8641016	34	3	ranged	range	VERB
bjos-8641016	34	4	from	from	ADP
bjos-8641016	34	5	18	18	NUM
bjos-8641016	34	6	to	to	PART
bjos-8641016	34	7	72	72	NUM
bjos-8641016	34	8	years	year	NOUN
bjos-8641016	34	9	(	(	PUNCT
bjos-8641016	34	10	mean	mean	VERB
bjos-8641016	34	11	:	:	PUNCT
bjos-8641016	34	12	43.4	43.4	NUM
bjos-8641016	34	13	years	year	NOUN
bjos-8641016	34	14	)	)	PUNCT
bjos-8641016	34	15	.	.	PUNCT
bjos-8641016	35	1	seventy	seventy	NUM
bjos-8641016	35	2	-	-	PUNCT
bjos-8641016	35	3	seven	seven	NUM
bjos-8641016	35	4	patients	patient	NOUN
bjos-8641016	35	5	had	have	VERB
bjos-8641016	35	6	papillary	papillary	ADJ
bjos-8641016	35	7	carcinoma	carcinoma	NOUN
bjos-8641016	35	8	and	and	CCONJ
bjos-8641016	35	9	11	11	NUM
bjos-8641016	35	10	had	have	VERB
bjos-8641016	35	11	follicular	follicular	ADJ
bjos-8641016	35	12	carcinoma	carcinoma	NOUN
bjos-8641016	35	13	.	.	PUNCT
bjos-8641016	36	1	most	most	ADJ
bjos-8641016	36	2	participants	participant	NOUN
bjos-8641016	36	3	(	(	PUNCT
bjos-8641016	36	4	52.3	52.3	NUM
bjos-8641016	36	5	%	%	NOUN
bjos-8641016	36	6	)	)	PUNCT
bjos-8641016	36	7	were	be	AUX
bjos-8641016	36	8	married	marry	VERB
bjos-8641016	36	9	,	,	PUNCT
bjos-8641016	36	10	5.7	5.7	NUM
bjos-8641016	36	11	%	%	NOUN
bjos-8641016	36	12	were	be	AUX
bjos-8641016	36	13	illiterate	illiterate	ADJ
bjos-8641016	36	14	,	,	PUNCT
bjos-8641016	36	15	and	and	CCONJ
bjos-8641016	36	16	39.8	39.8	NUM
bjos-8641016	36	17	%	%	NOUN
bjos-8641016	36	18	completed	complete	VERB
bjos-8641016	36	19	high	high	ADJ
bjos-8641016	36	20	school	school	NOUN
bjos-8641016	36	21	.	.	PUNCT
bjos-8641016	37	1	saliva	saliva	NOUN
bjos-8641016	37	2	was	be	AUX
bjos-8641016	37	3	collected	collect	VERB
bjos-8641016	37	4	initially	initially	ADV
bjos-8641016	37	5	from	from	ADP
bjos-8641016	37	6	88	88	NUM
bjos-8641016	37	7	patients	patient	NOUN
bjos-8641016	37	8	,	,	PUNCT
bjos-8641016	37	9	but	but	CCONJ
bjos-8641016	37	10	only	only	ADV
bjos-8641016	37	11	25	25	NUM
bjos-8641016	37	12	continued	continue	VERB
bjos-8641016	37	13	to	to	PART
bjos-8641016	37	14	participate	participate	VERB
bjos-8641016	37	15	in	in	ADP
bjos-8641016	37	16	the	the	DET
bjos-8641016	37	17	study	study	NOUN
bjos-8641016	37	18	for	for	ADP
bjos-8641016	37	19	sialometry	sialometry	NOUN
bjos-8641016	37	20	3	3	NUM
bjos-8641016	37	21	months	month	NOUN
bjos-8641016	37	22	after	after	ADP
bjos-8641016	37	23	the	the	DET
bjos-8641016	37	24	administration	administration	NOUN
bjos-8641016	37	25	of	of	ADP
bjos-8641016	37	26	iodine	iodine	NOUN
bjos-8641016	37	27	131	131	NUM
bjos-8641016	37	28	.	.	PUNCT
bjos-8641016	38	1	a	a	DET
bjos-8641016	38	2	decrease	decrease	NOUN
bjos-8641016	38	3	in	in	ADP
bjos-8641016	38	4	the	the	DET
bjos-8641016	38	5	mean	mean	ADJ
bjos-8641016	38	6	non	non	ADJ
bjos-8641016	38	7	-	-	ADJ
bjos-8641016	38	8	stimulated	stimulated	ADJ
bjos-8641016	38	9	and	and	CCONJ
bjos-8641016	38	10	stimulated	stimulate	VERB
bjos-8641016	38	11	salivary	salivary	ADJ
bjos-8641016	38	12	flow	flow	NOUN
bjos-8641016	38	13	rates	rate	NOUN
bjos-8641016	38	14	was	be	AUX
bjos-8641016	38	15	observed	observe	VERB
bjos-8641016	38	16	between	between	ADP
bjos-8641016	38	17	the	the	DET
bjos-8641016	38	18	first	first	ADJ
bjos-8641016	38	19	(	(	PUNCT
bjos-8641016	38	20	before	before	ADP
bjos-8641016	38	21	radioiodine	radioiodine	NOUN
bjos-8641016	38	22	therapy	therapy	NOUN
bjos-8641016	38	23	)	)	PUNCT
bjos-8641016	38	24	and	and	CCONJ
bjos-8641016	38	25	second	second	ADJ
bjos-8641016	38	26	evaluation	evaluation	NOUN
bjos-8641016	38	27	(	(	PUNCT
bjos-8641016	38	28	10	10	NUM
bjos-8641016	38	29	days	day	NOUN
bjos-8641016	38	30	after	after	ADP
bjos-8641016	38	31	therapy	therapy	NOUN
bjos-8641016	38	32	)	)	PUNCT
bjos-8641016	38	33	.	.	PUNCT
bjos-8641016	39	1	in	in	ADP
bjos-8641016	39	2	contrast	contrast	NOUN
bjos-8641016	39	3	,	,	PUNCT
bjos-8641016	39	4	mean	mean	VERB
bjos-8641016	39	5	non	non	ADJ
bjos-8641016	39	6	-	-	ADJ
bjos-8641016	39	7	stimulated	stimulated	ADJ
bjos-8641016	39	8	and	and	CCONJ
bjos-8641016	39	9	stimulated	stimulate	VERB
bjos-8641016	39	10	salivary	salivary	ADJ
bjos-8641016	39	11	flow	flow	NOUN
bjos-8641016	39	12	increased	increase	VERB
bjos-8641016	39	13	between	between	ADP
bjos-8641016	39	14	the	the	DET
bjos-8641016	39	15	second	second	ADJ
bjos-8641016	39	16	and	and	CCONJ
bjos-8641016	39	17	third	third	ADJ
bjos-8641016	39	18	evaluation	evaluation	NOUN
bjos-8641016	39	19	(	(	PUNCT
bjos-8641016	39	20	3	3	NUM
bjos-8641016	39	21	months	month	NOUN
bjos-8641016	39	22	after	after	ADP
bjos-8641016	39	23	therapy	therapy	NOUN
bjos-8641016	39	24	)	)	PUNCT
bjos-8641016	39	25	.	.	PUNCT
bjos-8641016	40	1	these	these	DET
bjos-8641016	40	2	differences	difference	NOUN
bjos-8641016	40	3	were	be	AUX
bjos-8641016	40	4	statistically	statistically	ADV
bjos-8641016	40	5	significant	significant	ADJ
bjos-8641016	40	6	for	for	ADP
bjos-8641016	40	7	non	non	ADJ
bjos-8641016	40	8	-	-	ADJ
bjos-8641016	40	9	stimulated	stimulated	ADJ
bjos-8641016	40	10	salivary	salivary	ADJ
bjos-8641016	40	11	flow	flow	NOUN
bjos-8641016	40	12	between	between	ADP
bjos-8641016	40	13	the	the	DET
bjos-8641016	40	14	second	second	ADJ
bjos-8641016	40	15	and	and	CCONJ
bjos-8641016	40	16	third	third	ADJ
bjos-8641016	40	17	evaluations	evaluation	NOUN
bjos-8641016	40	18	(	(	PUNCT
bjos-8641016	40	19	p<0.020	p<0.020	NOUN
bjos-8641016	40	20	)	)	PUNCT
bjos-8641016	40	21	and	and	CCONJ
bjos-8641016	40	22	for	for	ADP
bjos-8641016	40	23	stimulated	stimulated	ADJ
bjos-8641016	40	24	salivary	salivary	ADJ
bjos-8641016	40	25	flow	flow	NOUN
bjos-8641016	40	26	between	between	ADP
bjos-8641016	40	27	the	the	DET
bjos-8641016	40	28	first	first	ADJ
bjos-8641016	40	29	and	and	CCONJ
bjos-8641016	40	30	second	second	ADJ
bjos-8641016	40	31	evaluations	evaluation	NOUN
bjos-8641016	40	32	(	(	PUNCT
bjos-8641016	40	33	p<0.010	p<0.010	NOUN
bjos-8641016	40	34	)	)	PUNCT
bjos-8641016	40	35	(	(	PUNCT
bjos-8641016	40	36	tables	table	NOUN
bjos-8641016	40	37	1	1	NUM
bjos-8641016	40	38	and	and	CCONJ
bjos-8641016	40	39	2	2	NUM
bjos-8641016	40	40	)	)	PUNCT
bjos-8641016	40	41	.	.	PUNCT
bjos-8641016	41	1	xerostomia	xerostomia	PROPN
bjos-8641016	41	2	before	before	SCONJ
bjos-8641016	41	3	radioiodine	radioiodine	NOUN
bjos-8641016	41	4	was	be	AUX
bjos-8641016	41	5	reported	report	VERB
bjos-8641016	41	6	by	by	ADP
bjos-8641016	41	7	36.4	36.4	NUM
bjos-8641016	41	8	%	%	NOUN
bjos-8641016	41	9	of	of	ADP
bjos-8641016	41	10	the	the	DET
bjos-8641016	41	11	patients	patient	NOUN
bjos-8641016	41	12	.	.	PUNCT
bjos-8641016	42	1	after	after	ADP
bjos-8641016	42	2	10	10	NUM
bjos-8641016	42	3	days	day	NOUN
bjos-8641016	42	4	of	of	ADP
bjos-8641016	42	5	radioiodine	radioiodine	NOUN
bjos-8641016	42	6	therapy	therapy	NOUN
bjos-8641016	42	7	,	,	PUNCT
bjos-8641016	42	8	71	71	NUM
bjos-8641016	42	9	(	(	PUNCT
bjos-8641016	42	10	100	100	NUM
bjos-8641016	42	11	%	%	NOUN
bjos-8641016	42	12	)	)	PUNCT
bjos-8641016	42	13	participants	participant	NOUN
bjos-8641016	42	14	were	be	AUX
bjos-8641016	42	15	reassessed	reassess	VERB
bjos-8641016	42	16	and	and	CCONJ
bjos-8641016	42	17	42	42	NUM
bjos-8641016	42	18	(	(	PUNCT
bjos-8641016	42	19	59.15	59.15	NUM
bjos-8641016	42	20	%	%	NOUN
bjos-8641016	42	21	)	)	PUNCT
bjos-8641016	42	22	reported	report	VERB
bjos-8641016	42	23	xerostomia	xerostomia	NOUN
bjos-8641016	42	24	.	.	PUNCT
bjos-8641016	43	1	twenty	twenty	NUM
bjos-8641016	43	2	patients	patient	NOUN
bjos-8641016	43	3	did	do	AUX
bjos-8641016	43	4	not	not	PART
bjos-8641016	43	5	report	report	VERB
bjos-8641016	43	6	xerostomia	xerostomia	NOUN
bjos-8641016	43	7	prior	prior	ADV
bjos-8641016	43	8	to	to	ADP
bjos-8641016	43	9	therapy	therapy	NOUN
bjos-8641016	43	10	.	.	PUNCT
bjos-8641016	44	1	after	after	ADP
bjos-8641016	44	2	3	3	NUM
bjos-8641016	44	3	months	month	NOUN
bjos-8641016	44	4	,	,	PUNCT
bjos-8641016	44	5	only	only	ADV
bjos-8641016	44	6	5	5	NUM
bjos-8641016	44	7	(	(	PUNCT
bjos-8641016	44	8	25	25	NUM
bjos-8641016	44	9	%	%	NOUN
bjos-8641016	44	10	)	)	PUNCT
bjos-8641016	44	11	among	among	ADP
bjos-8641016	44	12	the	the	DET
bjos-8641016	44	13	25	25	NUM
bjos-8641016	44	14	(	(	PUNCT
bjos-8641016	44	15	100	100	NUM
bjos-8641016	44	16	%	%	NOUN
bjos-8641016	44	17	)	)	PUNCT
bjos-8641016	44	18	patients	patient	NOUN
bjos-8641016	44	19	had	have	VERB
bjos-8641016	44	20	xerostomia	xerostomia	NOUN
bjos-8641016	44	21	,	,	PUNCT
bjos-8641016	44	22	and	and	CCONJ
bjos-8641016	44	23	three	three	NUM
bjos-8641016	44	24	of	of	ADP
bjos-8641016	44	25	these	these	DET
bjos-8641016	44	26	five	five	NUM
bjos-8641016	44	27	reported	report	VERB
bjos-8641016	44	28	symptoms	symptom	NOUN
bjos-8641016	44	29	prior	prior	ADV
bjos-8641016	44	30	to	to	ADP
bjos-8641016	44	31	therapy	therapy	NOUN
bjos-8641016	44	32	(	(	PUNCT
bjos-8641016	44	33	table	table	NOUN
bjos-8641016	44	34	3	3	NUM
bjos-8641016	44	35	)	)	PUNCT
bjos-8641016	44	36	.	.	PUNCT
bjos-8641016	45	1	discussion	discussion	NOUN
bjos-8641016	45	2	it	it	PRON
bjos-8641016	45	3	is	be	AUX
bjos-8641016	45	4	important	important	ADJ
bjos-8641016	45	5	to	to	PART
bjos-8641016	45	6	provide	provide	VERB
bjos-8641016	45	7	best	good	ADJ
bjos-8641016	45	8	-	-	PUNCT
bjos-8641016	45	9	quality	quality	NOUN
bjos-8641016	45	10	care	care	NOUN
bjos-8641016	45	11	to	to	PART
bjos-8641016	45	12	patient	patient	VERB
bjos-8641016	45	13	with	with	ADP
bjos-8641016	45	14	differentiated	differentiated	ADJ
bjos-8641016	45	15	thyroid	thyroid	NOUN
bjos-8641016	45	16	carcinoma	carcinoma	NOUN
bjos-8641016	45	17	,	,	PUNCT
bjos-8641016	45	18	so	so	ADV
bjos-8641016	45	19	knowledge	knowledge	NOUN
bjos-8641016	45	20	of	of	ADP
bjos-8641016	45	21	non	non	ADJ
bjos-8641016	45	22	-	-	ADJ
bjos-8641016	45	23	stimulated	stimulated	ADJ
bjos-8641016	45	24	salivary	salivary	ADJ
bjos-8641016	45	25	flow	flow	NOUN
bjos-8641016	45	26	1st	1st	ADJ
bjos-8641016	45	27	evaluation	evaluation	NOUN
bjos-8641016	45	28	2nd	2nd	ADJ
bjos-8641016	45	29	evaluation	evaluation	NOUN
bjos-8641016	45	30	mean	mean	NOUN
bjos-8641016	45	31	sd	sd	AUX
bjos-8641016	45	32	mean	mean	VERB
bjos-8641016	45	33	sd	sd	ADP
bjos-8641016	45	34	t	t	PROPN
bjos-8641016	45	35	p	p	NOUN
bjos-8641016	45	36	0.4384	0.4384	NUM
bjos-8641016	45	37	0.3039	0.3039	NUM
bjos-8641016	45	38	0.3600	0.3600	NUM
bjos-8641016	45	39	0.2540	0.2540	NUM
bjos-8641016	45	40	1.383	1.383	NUM
bjos-8641016	45	41	0.179	0.179	NUM
bjos-8641016	45	42	1st	1st	ADJ
bjos-8641016	45	43	evaluation	evaluation	NOUN
bjos-8641016	45	44	3rd	3rd	ADJ
bjos-8641016	45	45	evaluation	evaluation	NOUN
bjos-8641016	45	46	mean	mean	NOUN
bjos-8641016	46	1	sd	sd	AUX
bjos-8641016	46	2	mean	mean	VERB
bjos-8641016	46	3	sd	sd	ADP
bjos-8641016	46	4	t	t	PROPN
bjos-8641016	46	5	p	p	NOUN
bjos-8641016	46	6	0.4384	0.4384	NUM
bjos-8641016	46	7	0.3039	0.3039	NUM
bjos-8641016	46	8	0.5428	0.5428	NUM
bjos-8641016	46	9	0.4564	0.4564	NUM
bjos-8641016	46	10	-1.074	-1.074	PUNCT
bjos-8641016	46	11	0.293	0.293	NUM
bjos-8641016	46	12	2nd	2nd	ADJ
bjos-8641016	46	13	evaluation	evaluation	NOUN
bjos-8641016	46	14	3rd	3rd	ADJ
bjos-8641016	46	15	evaluation	evaluation	NOUN
bjos-8641016	46	16	mean	mean	NOUN
bjos-8641016	46	17	sd	sd	AUX
bjos-8641016	46	18	mean	mean	VERB
bjos-8641016	46	19	sd	sd	ADP
bjos-8641016	46	20	t	t	PROPN
bjos-8641016	46	21	p	p	X
bjos-8641016	46	22	0.3600	0.3600	NUM
bjos-8641016	46	23	0.2540	0.2540	NUM
bjos-8641016	46	24	0.5428	0.5428	NUM
bjos-8641016	46	25	0.4564	0.4564	NUM
bjos-8641016	46	26	-2.491	-2.491	PUNCT
bjos-8641016	46	27	0.020	0.020	NUM
bjos-8641016	46	28	table	table	NOUN
bjos-8641016	46	29	1	1	NUM
bjos-8641016	46	30	.	.	PUNCT
bjos-8641016	46	31	comparison	comparison	NOUN
bjos-8641016	46	32	of	of	ADP
bjos-8641016	46	33	non	non	ADJ
bjos-8641016	46	34	-	-	ADJ
bjos-8641016	46	35	stimulated	stimulated	ADJ
bjos-8641016	46	36	salivary	salivary	ADJ
bjos-8641016	46	37	flow	flow	NOUN
bjos-8641016	46	38	before	before	ADP
bjos-8641016	46	39	radioiodine	radioiodine	NOUN
bjos-8641016	46	40	therapy	therapy	NOUN
bjos-8641016	46	41	(	(	PUNCT
bjos-8641016	46	42	1st	1st	ADJ
bjos-8641016	46	43	evaluation	evaluation	NOUN
bjos-8641016	46	44	)	)	PUNCT
bjos-8641016	46	45	,	,	PUNCT
bjos-8641016	46	46	10	10	NUM
bjos-8641016	46	47	days	day	NOUN
bjos-8641016	46	48	(	(	PUNCT
bjos-8641016	46	49	2nd	2nd	ADJ
bjos-8641016	46	50	evaluation	evaluation	NOUN
bjos-8641016	46	51	)	)	PUNCT
bjos-8641016	46	52	and	and	CCONJ
bjos-8641016	46	53	3	3	NUM
bjos-8641016	46	54	months	month	NOUN
bjos-8641016	46	55	(	(	PUNCT
bjos-8641016	46	56	3rd	3rd	ADJ
bjos-8641016	46	57	evaluation	evaluation	NOUN
bjos-8641016	46	58	)	)	PUNCT
bjos-8641016	46	59	after	after	ADP
bjos-8641016	46	60	therapy	therapy	NOUN
bjos-8641016	46	61	in	in	ADP
bjos-8641016	46	62	25	25	NUM
bjos-8641016	46	63	patients	patient	NOUN
bjos-8641016	46	64	submitted	submit	VERB
bjos-8641016	46	65	to	to	ADP
bjos-8641016	46	66	thyroidectomy	thyroidectomy	NOUN
bjos-8641016	46	67	*	*	PUNCT
bjos-8641016	46	68	.	.	PUNCT
bjos-8641016	47	1	results	result	NOUN
bjos-8641016	47	2	are	be	AUX
bjos-8641016	47	3	reported	report	VERB
bjos-8641016	47	4	as	as	ADP
bjos-8641016	47	5	mean	mean	ADJ
bjos-8641016	47	6	and	and	CCONJ
bjos-8641016	47	7	standard	standard	ADJ
bjos-8641016	47	8	deviation	deviation	NOUN
bjos-8641016	47	9	(	(	PUNCT
bjos-8641016	47	10	sd	sd	NOUN
bjos-8641016	47	11	)	)	PUNCT
bjos-8641016	47	12	.	.	PUNCT
bjos-8641016	48	1	p<0.05	p<0.05	NOUN
bjos-8641016	48	2	(	(	PUNCT
bjos-8641016	48	3	paired	pair	VERB
bjos-8641016	48	4	t	t	NOUN
bjos-8641016	48	5	-	-	PUNCT
bjos-8641016	48	6	test	test	NOUN
bjos-8641016	48	7	)	)	PUNCT
bjos-8641016	48	8	.	.	PUNCT
bjos-8641016	49	1	*	*	PUNCT
bjos-8641016	49	2	only	only	ADV
bjos-8641016	49	3	25	25	NUM
bjos-8641016	49	4	participants	participant	NOUN
bjos-8641016	49	5	were	be	AUX
bjos-8641016	49	6	submitted	submit	VERB
bjos-8641016	49	7	to	to	PART
bjos-8641016	49	8	sialometry	sialometry	NOUN
bjos-8641016	49	9	3	3	NUM
bjos-8641016	49	10	months	month	NOUN
bjos-8641016	49	11	after	after	ADP
bjos-8641016	49	12	the	the	DET
bjos-8641016	49	13	administration	administration	NOUN
bjos-8641016	49	14	of	of	ADP
bjos-8641016	49	15	iodine	iodine	NOUN
bjos-8641016	49	16	131	131	NUM
bjos-8641016	49	17	.	.	PUNCT
bjos-8641016	50	1	profile	profile	NOUN
bjos-8641016	50	2	of	of	ADP
bjos-8641016	50	3	salivary	salivary	ADJ
bjos-8641016	50	4	gland	gland	NOUN
bjos-8641016	50	5	flow	flow	NOUN
bjos-8641016	50	6	dysfunctions	dysfunction	NOUN
bjos-8641016	50	7	in	in	ADP
bjos-8641016	50	8	patients	patient	NOUN
bjos-8641016	50	9	with	with	ADP
bjos-8641016	50	10	differentiated	differentiated	ADJ
bjos-8641016	50	11	thyroid	thyroid	NOUN
bjos-8641016	50	12	carcinoma	carcinoma	NOUN
bjos-8641016	50	13	submitted	submit	VERB
bjos-8641016	50	14	to	to	PART
bjos-8641016	50	15	radioiodine	radioiodine	VERB
bjos-8641016	50	16	therapy	therapy	NOUN
bjos-8641016	50	17	braz	braz	PROPN
bjos-8641016	50	18	j	j	PROPN
bjos-8641016	50	19	oral	oral	PROPN
bjos-8641016	50	20	sci	sci	PROPN
bjos-8641016	50	21	.	.	PUNCT
bjos-8641016	51	1	12(3):169	12(3):169	NUM
bjos-8641016	51	2	-	-	SYM
bjos-8641016	51	3	172	172	NUM
bjos-8641016	51	4	171171171171171	171171171171171	NUM
bjos-8641016	51	5	xerostomia	xerostomia	NOUN
bjos-8641016	51	6	before	before	ADP
bjos-8641016	51	7	*	*	PUNCT
bjos-8641016	51	8	after	after	ADP
bjos-8641016	51	9	10	10	NUM
bjos-8641016	51	10	days	day	NOUN
bjos-8641016	51	11	*	*	PUNCT
bjos-8641016	51	12	after	after	ADP
bjos-8641016	51	13	3	3	NUM
bjos-8641016	51	14	months	month	NOUN
bjos-8641016	51	15	*	*	PUNCT
bjos-8641016	51	16	n	n	PRON
bjos-8641016	51	17	=	=	SYM
bjos-8641016	51	18	88	88	NUM
bjos-8641016	51	19	(	(	PUNCT
bjos-8641016	51	20	100	100	NUM
bjos-8641016	51	21	%	%	NOUN
bjos-8641016	51	22	)	)	PUNCT
bjos-8641016	52	1	n=71	n=71	NOUN
bjos-8641016	52	2	(	(	PUNCT
bjos-8641016	52	3	100	100	NUM
bjos-8641016	52	4	%	%	NOUN
bjos-8641016	52	5	)	)	PUNCT
bjos-8641016	52	6	n=25	n=25	PROPN
bjos-8641016	52	7	(	(	PUNCT
bjos-8641016	52	8	100	100	NUM
bjos-8641016	52	9	%	%	NOUN
bjos-8641016	52	10	)	)	PUNCT
bjos-8641016	52	11	present	present	ADJ
bjos-8641016	52	12	32(36.4	32(36.4	NUM
bjos-8641016	52	13	%	%	NOUN
bjos-8641016	52	14	)	)	PUNCT
bjos-8641016	52	15	42(59.15	42(59.15	NUM
bjos-8641016	52	16	%	%	NOUN
bjos-8641016	52	17	)	)	PUNCT
bjos-8641016	52	18	5	5	NUM
bjos-8641016	52	19	(	(	PUNCT
bjos-8641016	52	20	25	25	NUM
bjos-8641016	52	21	%	%	NOUN
bjos-8641016	52	22	)	)	PUNCT
bjos-8641016	52	23	absent	absent	ADJ
bjos-8641016	52	24	56(63.6	56(63.6	NUM
bjos-8641016	52	25	%	%	NOUN
bjos-8641016	52	26	)	)	PUNCT
bjos-8641016	53	1	29(40.85	29(40.85	NUM
bjos-8641016	53	2	%	%	NOUN
bjos-8641016	53	3	)	)	PUNCT
bjos-8641016	54	1	20(75	20(75	NUM
bjos-8641016	54	2	%	%	NOUN
bjos-8641016	54	3	)	)	PUNCT
bjos-8641016	54	4	table	table	NOUN
bjos-8641016	54	5	3	3	NUM
bjos-8641016	54	6	.	.	PUNCT
bjos-8641016	54	7	distribution	distribution	NOUN
bjos-8641016	54	8	of	of	ADP
bjos-8641016	54	9	patients	patient	NOUN
bjos-8641016	54	10	with	with	ADP
bjos-8641016	54	11	xerostomia	xerostomia	NOUN
bjos-8641016	54	12	before	before	ADV
bjos-8641016	54	13	,	,	PUNCT
bjos-8641016	54	14	after	after	ADP
bjos-8641016	54	15	10	10	NUM
bjos-8641016	54	16	days	day	NOUN
bjos-8641016	54	17	and	and	CCONJ
bjos-8641016	54	18	after	after	ADP
bjos-8641016	54	19	3	3	NUM
bjos-8641016	54	20	months	month	NOUN
bjos-8641016	54	21	of	of	ADP
bjos-8641016	54	22	radioiodine	radioiodine	NOUN
bjos-8641016	54	23	131	131	NUM
bjos-8641016	54	24	therapy	therapy	NOUN
bjos-8641016	54	25	.	.	PUNCT
bjos-8641016	55	1	*	*	PUNCT
bjos-8641016	55	2	radioiodine	radioiodine	NOUN
bjos-8641016	55	3	131	131	NUM
bjos-8641016	55	4	therapy	therapy	NOUN
bjos-8641016	55	5	complications	complication	NOUN
bjos-8641016	55	6	and	and	CCONJ
bjos-8641016	55	7	associated	associated	ADJ
bjos-8641016	55	8	factors	factor	NOUN
bjos-8641016	55	9	to	to	ADP
bjos-8641016	55	10	high	high	ADJ
bjos-8641016	55	11	doses	dose	NOUN
bjos-8641016	55	12	of	of	ADP
bjos-8641016	55	13	radioactive	radioactive	ADJ
bjos-8641016	55	14	iodine	iodine	NOUN
bjos-8641016	55	15	therapy	therapy	NOUN
bjos-8641016	55	16	(	(	PUNCT
bjos-8641016	55	17	>	>	SYM
bjos-8641016	55	18	100	100	NUM
bjos-8641016	55	19	mci	mci	NOUN
bjos-8641016	55	20	)	)	PUNCT
bjos-8641016	55	21	must	must	AUX
bjos-8641016	55	22	be	be	AUX
bjos-8641016	55	23	investigated12	investigated12	ADJ
bjos-8641016	55	24	.	.	PUNCT
bjos-8641016	56	1	there	there	PRON
bjos-8641016	56	2	are	be	VERB
bjos-8641016	56	3	few	few	ADJ
bjos-8641016	56	4	brazilian	brazilian	ADJ
bjos-8641016	56	5	studies	study	NOUN
bjos-8641016	56	6	about	about	ADP
bjos-8641016	56	7	repercussion	repercussion	NOUN
bjos-8641016	56	8	of	of	ADP
bjos-8641016	56	9	iodine	iodine	NOUN
bjos-8641016	56	10	ablation	ablation	NOUN
bjos-8641016	56	11	on	on	ADP
bjos-8641016	56	12	the	the	DET
bjos-8641016	56	13	salivary	salivary	ADJ
bjos-8641016	56	14	glands12	glands12	NOUN
bjos-8641016	56	15	-	-	PUNCT
bjos-8641016	56	16	13	13	NUM
bjos-8641016	56	17	.	.	PUNCT
bjos-8641016	57	1	although	although	SCONJ
bjos-8641016	57	2	xerostomia	xerostomia	PROPN
bjos-8641016	57	3	was	be	AUX
bjos-8641016	57	4	evaluated	evaluate	VERB
bjos-8641016	57	5	in	in	ADP
bjos-8641016	57	6	these	these	DET
bjos-8641016	57	7	studies	study	NOUN
bjos-8641016	57	8	,	,	PUNCT
bjos-8641016	57	9	no	no	DET
bjos-8641016	57	10	measurement	measurement	NOUN
bjos-8641016	57	11	of	of	ADP
bjos-8641016	57	12	salivary	salivary	ADJ
bjos-8641016	57	13	flow	flow	NOUN
bjos-8641016	57	14	to	to	PART
bjos-8641016	57	15	diagnose	diagnose	NOUN
bjos-8641016	57	16	hyposalivation	hyposalivation	NOUN
bjos-8641016	57	17	was	be	AUX
bjos-8641016	57	18	done	do	VERB
bjos-8641016	57	19	in	in	ADP
bjos-8641016	57	20	these	these	DET
bjos-8641016	57	21	investigations	investigation	NOUN
bjos-8641016	57	22	.	.	PUNCT
bjos-8641016	58	1	the	the	DET
bjos-8641016	58	2	present	present	ADJ
bjos-8641016	58	3	study	study	NOUN
bjos-8641016	58	4	showed	show	VERB
bjos-8641016	58	5	an	an	DET
bjos-8641016	58	6	increase	increase	NOUN
bjos-8641016	58	7	of	of	ADP
bjos-8641016	58	8	patients	patient	NOUN
bjos-8641016	58	9	with	with	ADP
bjos-8641016	58	10	symptoms	symptom	NOUN
bjos-8641016	58	11	of	of	ADP
bjos-8641016	58	12	xerostomia	xerostomia	NOUN
bjos-8641016	58	13	from	from	ADP
bjos-8641016	58	14	36.4	36.4	NUM
bjos-8641016	58	15	%	%	NOUN
bjos-8641016	58	16	(	(	PUNCT
bjos-8641016	58	17	before	before	ADP
bjos-8641016	58	18	radioiodine	radioiodine	NOUN
bjos-8641016	58	19	therapy	therapy	NOUN
bjos-8641016	58	20	)	)	PUNCT
bjos-8641016	58	21	to	to	ADP
bjos-8641016	58	22	59.15	59.15	NUM
bjos-8641016	58	23	%	%	NOUN
bjos-8641016	58	24	(	(	PUNCT
bjos-8641016	58	25	10	10	NUM
bjos-8641016	58	26	days	day	NOUN
bjos-8641016	58	27	after	after	ADP
bjos-8641016	58	28	therapy	therapy	NOUN
bjos-8641016	58	29	)	)	PUNCT
bjos-8641016	58	30	.	.	PUNCT
bjos-8641016	59	1	after	after	ADP
bjos-8641016	59	2	3	3	NUM
bjos-8641016	59	3	months	month	NOUN
bjos-8641016	59	4	,	,	PUNCT
bjos-8641016	59	5	only	only	ADV
bjos-8641016	59	6	5	5	NUM
bjos-8641016	59	7	(	(	PUNCT
bjos-8641016	59	8	25	25	NUM
bjos-8641016	59	9	%	%	NOUN
bjos-8641016	59	10	)	)	PUNCT
bjos-8641016	59	11	of	of	ADP
bjos-8641016	59	12	the	the	DET
bjos-8641016	59	13	25	25	NUM
bjos-8641016	59	14	reevaluated	reevaluate	VERB
bjos-8641016	59	15	patients	patient	NOUN
bjos-8641016	59	16	reported	report	VERB
bjos-8641016	59	17	this	this	DET
bjos-8641016	59	18	symptom	symptom	NOUN
bjos-8641016	59	19	.	.	PUNCT
bjos-8641016	60	1	similar	similar	ADJ
bjos-8641016	60	2	results	result	NOUN
bjos-8641016	60	3	were	be	AUX
bjos-8641016	60	4	described	describe	VERB
bjos-8641016	60	5	in	in	ADP
bjos-8641016	60	6	a	a	DET
bjos-8641016	60	7	longitudinal	longitudinal	ADJ
bjos-8641016	60	8	study	study	NOUN
bjos-8641016	60	9	in	in	ADP
bjos-8641016	60	10	which	which	PRON
bjos-8641016	60	11	the	the	DET
bjos-8641016	60	12	population	population	NOUN
bjos-8641016	60	13	was	be	AUX
bjos-8641016	60	14	submitted	submit	VERB
bjos-8641016	60	15	to	to	ADP
bjos-8641016	60	16	more	more	ADJ
bjos-8641016	60	17	than	than	ADP
bjos-8641016	60	18	one	one	NUM
bjos-8641016	60	19	evaluation	evaluation	NOUN
bjos-8641016	60	20	and	and	CCONJ
bjos-8641016	60	21	a	a	DET
bjos-8641016	60	22	decrease	decrease	NOUN
bjos-8641016	60	23	in	in	ADP
bjos-8641016	60	24	the	the	DET
bjos-8641016	60	25	percentage	percentage	NOUN
bjos-8641016	60	26	of	of	ADP
bjos-8641016	60	27	patients	patient	NOUN
bjos-8641016	60	28	with	with	ADP
bjos-8641016	60	29	xerostomia	xerostomia	NOUN
bjos-8641016	60	30	was	be	AUX
bjos-8641016	60	31	observed	observe	VERB
bjos-8641016	60	32	several	several	ADJ
bjos-8641016	60	33	months	month	NOUN
bjos-8641016	60	34	after	after	ADP
bjos-8641016	60	35	treatment12	treatment12	NOUN
bjos-8641016	60	36	.	.	PUNCT
bjos-8641016	61	1	that	that	DET
bjos-8641016	61	2	study	study	NOUN
bjos-8641016	61	3	had	have	VERB
bjos-8641016	61	4	a	a	DET
bjos-8641016	61	5	follow	follow	VERB
bjos-8641016	61	6	-	-	PUNCT
bjos-8641016	61	7	up	up	NOUN
bjos-8641016	61	8	period	period	NOUN
bjos-8641016	61	9	of	of	ADP
bjos-8641016	61	10	3	3	NUM
bjos-8641016	61	11	months	month	NOUN
bjos-8641016	61	12	while	while	SCONJ
bjos-8641016	61	13	in	in	ADP
bjos-8641016	61	14	the	the	DET
bjos-8641016	61	15	preent	preent	PROPN
bjos-8641016	61	16	investigation	investigation	NOUN
bjos-8641016	61	17	the	the	DET
bjos-8641016	61	18	follow	follow	VERB
bjos-8641016	61	19	up	up	ADP
bjos-8641016	61	20	period	period	NOUN
bjos-8641016	61	21	was	be	AUX
bjos-8641016	61	22	8	8	NUM
bjos-8641016	61	23	months12	months12	NOUN
bjos-8641016	61	24	.	.	PUNCT
bjos-8641016	62	1	caglar	caglar	ADJ
bjos-8641016	62	2	et	et	PROPN
bjos-8641016	62	3	al.14	al.14	PROPN
bjos-8641016	62	4	evaluated	evaluate	VERB
bjos-8641016	62	5	subjective	subjective	ADJ
bjos-8641016	62	6	symptoms	symptom	NOUN
bjos-8641016	62	7	of	of	ADP
bjos-8641016	62	8	salivary	salivary	ADJ
bjos-8641016	62	9	gland	gland	NOUN
bjos-8641016	62	10	dysfunction	dysfunction	NOUN
bjos-8641016	62	11	in	in	ADP
bjos-8641016	62	12	39	39	NUM
bjos-8641016	62	13	patients	patient	NOUN
bjos-8641016	62	14	submitted	submit	VERB
bjos-8641016	62	15	to	to	PART
bjos-8641016	62	16	radioiodine	radioiodine	VERB
bjos-8641016	62	17	therapy	therapy	NOUN
bjos-8641016	62	18	.	.	PUNCT
bjos-8641016	63	1	twenty	twenty	NUM
bjos-8641016	63	2	-	-	PUNCT
bjos-8641016	63	3	one	one	NUM
bjos-8641016	63	4	(	(	PUNCT
bjos-8641016	63	5	54	54	NUM
bjos-8641016	63	6	%	%	NOUN
bjos-8641016	63	7	)	)	PUNCT
bjos-8641016	63	8	patients	patient	NOUN
bjos-8641016	63	9	developed	develop	VERB
bjos-8641016	63	10	xerostomia	xerostomia	NOUN
bjos-8641016	63	11	after	after	ADP
bjos-8641016	63	12	ablation	ablation	NOUN
bjos-8641016	63	13	with	with	ADP
bjos-8641016	63	14	iodine	iodine	NOUN
bjos-8641016	63	15	131	131	NUM
bjos-8641016	63	16	.	.	PUNCT
bjos-8641016	64	1	in	in	ADP
bjos-8641016	64	2	contrast	contrast	NOUN
bjos-8641016	64	3	,	,	PUNCT
bjos-8641016	64	4	grewel	grewel	PROPN
bjos-8641016	64	5	et	et	NOUN
bjos-8641016	64	6	al.9	al.9	PROPN
bjos-8641016	64	7	evaluated	evaluate	VERB
bjos-8641016	64	8	retrospectively	retrospectively	ADV
bjos-8641016	64	9	262	262	NUM
bjos-8641016	64	10	patients	patient	NOUN
bjos-8641016	64	11	in	in	ADP
bjos-8641016	64	12	the	the	DET
bjos-8641016	64	13	first	first	ADJ
bjos-8641016	64	14	year	year	NOUN
bjos-8641016	64	15	of	of	ADP
bjos-8641016	64	16	follow	follow	NOUN
bjos-8641016	64	17	-	-	PUNCT
bjos-8641016	64	18	up	up	NOUN
bjos-8641016	64	19	after	after	ADP
bjos-8641016	64	20	treatment	treatment	NOUN
bjos-8641016	64	21	with	with	ADP
bjos-8641016	64	22	high	high	ADJ
bjos-8641016	64	23	doses	dose	NOUN
bjos-8641016	64	24	of	of	ADP
bjos-8641016	64	25	iodine	iodine	NOUN
bjos-8641016	64	26	131	131	NUM
bjos-8641016	64	27	and	and	CCONJ
bjos-8641016	64	28	reported	report	VERB
bjos-8641016	64	29	17	17	NUM
bjos-8641016	64	30	%	%	NOUN
bjos-8641016	64	31	of	of	ADP
bjos-8641016	64	32	xerostomia	xerostomia	NOUN
bjos-8641016	64	33	.	.	PUNCT
bjos-8641016	65	1	this	this	DET
bjos-8641016	65	2	incidence	incidence	NOUN
bjos-8641016	65	3	of	of	ADP
bjos-8641016	65	4	xerostomia	xerostomia	NOUN
bjos-8641016	65	5	is	be	AUX
bjos-8641016	65	6	similar	similar	ADJ
bjos-8641016	65	7	to	to	ADP
bjos-8641016	65	8	the	the	DET
bjos-8641016	65	9	25	25	NUM
bjos-8641016	65	10	%	%	NOUN
bjos-8641016	65	11	observed	observe	VERB
bjos-8641016	65	12	in	in	ADP
bjos-8641016	65	13	the	the	DET
bjos-8641016	65	14	present	present	ADJ
bjos-8641016	65	15	study	study	NOUN
bjos-8641016	65	16	after	after	ADP
bjos-8641016	65	17	3	3	NUM
bjos-8641016	65	18	months	month	NOUN
bjos-8641016	65	19	of	of	ADP
bjos-8641016	65	20	radioiodine	radioiodine	NOUN
bjos-8641016	65	21	therapy	therapy	NOUN
bjos-8641016	65	22	.	.	PUNCT
bjos-8641016	66	1	however	however	ADV
bjos-8641016	66	2	,	,	PUNCT
bjos-8641016	66	3	in	in	ADP
bjos-8641016	66	4	both	both	DET
bjos-8641016	66	5	cited	cite	VERB
bjos-8641016	66	6	studies	study	NOUN
bjos-8641016	66	7	salivary	salivary	VERB
bjos-8641016	66	8	flow	flow	NOUN
bjos-8641016	66	9	was	be	AUX
bjos-8641016	66	10	not	not	PART
bjos-8641016	66	11	measured	measure	VERB
bjos-8641016	66	12	as	as	ADP
bjos-8641016	66	13	in	in	ADP
bjos-8641016	66	14	the	the	DET
bjos-8641016	66	15	present	present	ADJ
bjos-8641016	66	16	investigation	investigation	NOUN
bjos-8641016	66	17	.	.	PUNCT
bjos-8641016	67	1	both	both	DET
bjos-8641016	67	2	non	non	ADJ
bjos-8641016	67	3	-	-	ADJ
bjos-8641016	67	4	stimulated	stimulated	ADJ
bjos-8641016	67	5	and	and	CCONJ
bjos-8641016	67	6	stimulated	stimulate	VERB
bjos-8641016	67	7	mean	mean	NOUN
bjos-8641016	67	8	salivary	salivary	ADJ
bjos-8641016	67	9	flow	flow	NOUN
bjos-8641016	67	10	rates	rate	NOUN
bjos-8641016	67	11	decreased	decrease	VERB
bjos-8641016	67	12	between	between	ADP
bjos-8641016	67	13	the	the	DET
bjos-8641016	67	14	first	first	ADJ
bjos-8641016	67	15	(	(	PUNCT
bjos-8641016	67	16	before	before	ADP
bjos-8641016	67	17	radioiodine	radioiodine	NOUN
bjos-8641016	67	18	therapy	therapy	NOUN
bjos-8641016	67	19	)	)	PUNCT
bjos-8641016	67	20	and	and	CCONJ
bjos-8641016	67	21	second	second	ADJ
bjos-8641016	67	22	(	(	PUNCT
bjos-8641016	67	23	10	10	NUM
bjos-8641016	67	24	days	day	NOUN
bjos-8641016	67	25	after	after	ADP
bjos-8641016	67	26	therapy	therapy	NOUN
bjos-8641016	67	27	)	)	PUNCT
bjos-8641016	67	28	evaluation	evaluation	NOUN
bjos-8641016	67	29	.	.	PUNCT
bjos-8641016	68	1	in	in	ADP
bjos-8641016	68	2	contrast	contrast	NOUN
bjos-8641016	68	3	,	,	PUNCT
bjos-8641016	68	4	an	an	DET
bjos-8641016	68	5	increase	increase	NOUN
bjos-8641016	68	6	of	of	ADP
bjos-8641016	68	7	non	non	ADJ
bjos-8641016	68	8	-	-	ADJ
bjos-8641016	68	9	stimulated	stimulated	ADJ
bjos-8641016	68	10	and	and	CCONJ
bjos-8641016	68	11	stimulated	stimulate	VERB
bjos-8641016	68	12	mean	mean	NOUN
bjos-8641016	68	13	salivary	salivary	ADJ
bjos-8641016	68	14	flow	flow	NOUN
bjos-8641016	68	15	rates	rate	NOUN
bjos-8641016	68	16	was	be	AUX
bjos-8641016	68	17	observed	observe	VERB
bjos-8641016	68	18	between	between	ADP
bjos-8641016	68	19	the	the	DET
bjos-8641016	68	20	second	second	ADJ
bjos-8641016	68	21	and	and	CCONJ
bjos-8641016	68	22	third	third	ADJ
bjos-8641016	68	23	(	(	PUNCT
bjos-8641016	68	24	3	3	NUM
bjos-8641016	68	25	months	month	NOUN
bjos-8641016	68	26	after	after	ADP
bjos-8641016	68	27	therapy	therapy	NOUN
bjos-8641016	68	28	)	)	PUNCT
bjos-8641016	68	29	evaluations	evaluation	NOUN
bjos-8641016	68	30	,	,	PUNCT
bjos-8641016	68	31	i.e.	i.e.	X
bjos-8641016	68	32	,	,	PUNCT
bjos-8641016	68	33	salivary	salivary	ADJ
bjos-8641016	68	34	flow	flow	NOUN
bjos-8641016	68	35	rates	rate	NOUN
bjos-8641016	68	36	tended	tend	VERB
bjos-8641016	68	37	to	to	PART
bjos-8641016	68	38	return	return	VERB
bjos-8641016	68	39	to	to	ADP
bjos-8641016	68	40	baseline	baseline	VERB
bjos-8641016	68	41	after	after	ADP
bjos-8641016	68	42	3	3	NUM
bjos-8641016	68	43	months	month	NOUN
bjos-8641016	68	44	.	.	PUNCT
bjos-8641016	69	1	these	these	DET
bjos-8641016	69	2	findings	finding	NOUN
bjos-8641016	69	3	suggest	suggest	VERB
bjos-8641016	69	4	transient	transient	ADJ
bjos-8641016	69	5	alterations	alteration	NOUN
bjos-8641016	69	6	in	in	ADP
bjos-8641016	69	7	salivary	salivary	ADJ
bjos-8641016	69	8	flow	flow	NOUN
bjos-8641016	69	9	as	as	SCONJ
bjos-8641016	69	10	demonstrated	demonstrate	VERB
bjos-8641016	69	11	by	by	ADP
bjos-8641016	69	12	the	the	DET
bjos-8641016	69	13	observation	observation	NOUN
bjos-8641016	69	14	of	of	ADP
bjos-8641016	69	15	significant	significant	ADJ
bjos-8641016	69	16	differences	difference	NOUN
bjos-8641016	69	17	in	in	ADP
bjos-8641016	69	18	non	non	ADJ
bjos-8641016	69	19	-	-	ADJ
bjos-8641016	69	20	stimulated	stimulated	ADJ
bjos-8641016	69	21	salivary	salivary	ADJ
bjos-8641016	69	22	flow	flow	NOUN
bjos-8641016	69	23	between	between	ADP
bjos-8641016	69	24	the	the	DET
bjos-8641016	69	25	second	second	ADJ
bjos-8641016	69	26	and	and	CCONJ
bjos-8641016	69	27	third	third	ADJ
bjos-8641016	69	28	evaluations	evaluation	NOUN
bjos-8641016	69	29	(	(	PUNCT
bjos-8641016	69	30	p<0.020	p<0.020	NOUN
bjos-8641016	69	31	)	)	PUNCT
bjos-8641016	69	32	and	and	CCONJ
bjos-8641016	69	33	in	in	ADP
bjos-8641016	69	34	stimulated	stimulated	ADJ
bjos-8641016	69	35	salivary	salivary	ADJ
bjos-8641016	69	36	flow	flow	NOUN
bjos-8641016	69	37	between	between	ADP
bjos-8641016	69	38	the	the	DET
bjos-8641016	69	39	first	first	ADJ
bjos-8641016	69	40	and	and	CCONJ
bjos-8641016	69	41	second	second	ADJ
bjos-8641016	69	42	evaluations	evaluation	NOUN
bjos-8641016	69	43	(	(	PUNCT
bjos-8641016	69	44	p<0.010	p<0.010	NOUN
bjos-8641016	69	45	)	)	PUNCT
bjos-8641016	69	46	.	.	PUNCT
bjos-8641016	70	1	although	although	SCONJ
bjos-8641016	70	2	there	there	PRON
bjos-8641016	70	3	are	be	VERB
bjos-8641016	70	4	few	few	ADJ
bjos-8641016	70	5	data	datum	NOUN
bjos-8641016	70	6	about	about	ADP
bjos-8641016	70	7	salivary	salivary	ADJ
bjos-8641016	70	8	gland	gland	NOUN
bjos-8641016	70	9	dysfunction	dysfunction	NOUN
bjos-8641016	70	10	after	after	ADP
bjos-8641016	70	11	radioiodine	radioiodine	NOUN
bjos-8641016	70	12	therapy	therapy	NOUN
bjos-8641016	70	13	,	,	PUNCT
bjos-8641016	70	14	apparently	apparently	ADV
bjos-8641016	70	15	there	there	PRON
bjos-8641016	70	16	is	be	VERB
bjos-8641016	70	17	higher	high	ADJ
bjos-8641016	70	18	prevalence	prevalence	NOUN
bjos-8641016	70	19	of	of	ADP
bjos-8641016	70	20	transient	transient	ADJ
bjos-8641016	70	21	alterations9	alterations9	PROPN
bjos-8641016	70	22	.	.	PUNCT
bjos-8641016	71	1	there	there	PRON
bjos-8641016	71	2	are	be	VERB
bjos-8641016	71	3	various	various	ADJ
bjos-8641016	71	4	longitudinal	longitudinal	ADJ
bjos-8641016	71	5	studies	study	NOUN
bjos-8641016	71	6	about	about	ADP
bjos-8641016	71	7	postablation	postablation	NOUN
bjos-8641016	71	8	salivary	salivary	ADJ
bjos-8641016	71	9	gland	gland	NOUN
bjos-8641016	71	10	dysfunction	dysfunction	NOUN
bjos-8641016	71	11	,	,	PUNCT
bjos-8641016	71	12	but	but	CCONJ
bjos-8641016	71	13	they	they	PRON
bjos-8641016	71	14	are	be	AUX
bjos-8641016	71	15	based	base	VERB
bjos-8641016	71	16	on	on	ADP
bjos-8641016	71	17	subjective	subjective	ADJ
bjos-8641016	71	18	prospective	prospective	ADJ
bjos-8641016	71	19	analyses	analysis	NOUN
bjos-8641016	71	20	(	(	PUNCT
bjos-8641016	71	21	interviews	interview	NOUN
bjos-8641016	71	22	and	and	CCONJ
bjos-8641016	71	23	questionnaires	questionnaire	NOUN
bjos-8641016	71	24	)	)	PUNCT
bjos-8641016	71	25	of	of	ADP
bjos-8641016	71	26	glandular	glandular	ADJ
bjos-8641016	71	27	function8	function8	NOUN
bjos-8641016	71	28	-	-	PUNCT
bjos-8641016	71	29	9,12	9,12	NUM
bjos-8641016	71	30	.	.	PUNCT
bjos-8641016	72	1	generally	generally	ADV
bjos-8641016	72	2	,	,	PUNCT
bjos-8641016	72	3	objective	objective	ADJ
bjos-8641016	72	4	analysis	analysis	NOUN
bjos-8641016	72	5	of	of	ADP
bjos-8641016	72	6	glandular	glandular	ADJ
bjos-8641016	72	7	function	function	NOUN
bjos-8641016	72	8	has	have	AUX
bjos-8641016	72	9	been	be	AUX
bjos-8641016	72	10	done	do	VERB
bjos-8641016	72	11	by	by	ADP
bjos-8641016	72	12	scintigraphy	scintigraphy	NOUN
bjos-8641016	72	13	,	,	PUNCT
bjos-8641016	72	14	but	but	CCONJ
bjos-8641016	72	15	most	most	ADJ
bjos-8641016	72	16	of	of	ADP
bjos-8641016	72	17	these	these	DET
bjos-8641016	72	18	studies	study	NOUN
bjos-8641016	72	19	applied	apply	VERB
bjos-8641016	72	20	a	a	DET
bjos-8641016	72	21	cross	cross	ADJ
bjos-8641016	72	22	-	-	ADJ
bjos-8641016	72	23	sectional	sectional	ADJ
bjos-8641016	72	24	method	method	NOUN
bjos-8641016	72	25	to	to	PART
bjos-8641016	72	26	demonstrate	demonstrate	VERB
bjos-8641016	72	27	the	the	DET
bjos-8641016	72	28	occurrence	occurrence	NOUN
bjos-8641016	72	29	of	of	ADP
bjos-8641016	72	30	salivary	salivary	ADJ
bjos-8641016	72	31	disorders	disorder	NOUN
bjos-8641016	72	32	within	within	ADP
bjos-8641016	72	33	months	month	NOUN
bjos-8641016	72	34	after	after	ADP
bjos-8641016	72	35	treatment13	treatment13	NOUN
bjos-8641016	72	36	-	-	PUNCT
bjos-8641016	72	37	14	14	NUM
bjos-8641016	72	38	.	.	PUNCT
bjos-8641016	73	1	prospectively	prospectively	ADV
bjos-8641016	73	2	,	,	PUNCT
bjos-8641016	73	3	solans	solans	PROPN
bjos-8641016	73	4	et	et	NOUN
bjos-8641016	73	5	al.3	al.3	PROPN
bjos-8641016	73	6	evaluated	evaluate	VERB
bjos-8641016	73	7	glandular	glandular	ADJ
bjos-8641016	73	8	dysfunction	dysfunction	NOUN
bjos-8641016	73	9	by	by	ADP
bjos-8641016	73	10	scintigraphy	scintigraphy	NOUN
bjos-8641016	73	11	over	over	ADP
bjos-8641016	73	12	a	a	DET
bjos-8641016	73	13	period	period	NOUN
bjos-8641016	73	14	of	of	ADP
bjos-8641016	73	15	3	3	NUM
bjos-8641016	73	16	years	year	NOUN
bjos-8641016	73	17	.	.	PUNCT
bjos-8641016	74	1	however	however	ADV
bjos-8641016	74	2	,	,	PUNCT
bjos-8641016	74	3	the	the	DET
bjos-8641016	74	4	exam	exam	NOUN
bjos-8641016	74	5	was	be	AUX
bjos-8641016	74	6	performed	perform	VERB
bjos-8641016	74	7	annually	annually	ADV
bjos-8641016	74	8	,	,	PUNCT
bjos-8641016	74	9	i.e.	i.e.	X
bjos-8641016	74	10	,	,	PUNCT
bjos-8641016	74	11	the	the	DET
bjos-8641016	74	12	first	first	ADJ
bjos-8641016	74	13	evaluation	evaluation	NOUN
bjos-8641016	74	14	of	of	ADP
bjos-8641016	74	15	salivary	salivary	ADJ
bjos-8641016	74	16	gland	gland	NOUN
bjos-8641016	74	17	dysfunction	dysfunction	NOUN
bjos-8641016	74	18	was	be	AUX
bjos-8641016	74	19	made	make	VERB
bjos-8641016	74	20	only	only	ADV
bjos-8641016	74	21	one	one	NUM
bjos-8641016	74	22	year	year	NOUN
bjos-8641016	74	23	after	after	ADP
bjos-8641016	74	24	treatment	treatment	NOUN
bjos-8641016	74	25	.	.	PUNCT
bjos-8641016	75	1	contrastingly	contrastingly	ADV
bjos-8641016	75	2	,	,	PUNCT
bjos-8641016	75	3	in	in	ADP
bjos-8641016	75	4	the	the	DET
bjos-8641016	75	5	present	present	ADJ
bjos-8641016	75	6	study	study	NOUN
bjos-8641016	75	7	the	the	DET
bjos-8641016	75	8	glandular	glandular	ADJ
bjos-8641016	75	9	function	function	NOUN
bjos-8641016	75	10	was	be	AUX
bjos-8641016	75	11	evaluated	evaluate	VERB
bjos-8641016	75	12	objectively	objectively	ADV
bjos-8641016	75	13	in	in	ADP
bjos-8641016	75	14	25	25	NUM
bjos-8641016	75	15	patients	patient	NOUN
bjos-8641016	75	16	at	at	ADP
bjos-8641016	75	17	three	three	NUM
bjos-8641016	75	18	different	different	ADJ
bjos-8641016	75	19	time	time	NOUN
bjos-8641016	75	20	points	point	NOUN
bjos-8641016	75	21	(	(	PUNCT
bjos-8641016	75	22	before	before	ADP
bjos-8641016	75	23	,	,	PUNCT
bjos-8641016	75	24	10	10	NUM
bjos-8641016	75	25	days	day	NOUN
bjos-8641016	75	26	and	and	CCONJ
bjos-8641016	75	27	3	3	NUM
bjos-8641016	75	28	months	month	NOUN
bjos-8641016	75	29	after	after	ADP
bjos-8641016	75	30	radioiodine	radioiodine	NOUN
bjos-8641016	75	31	therapy	therapy	NOUN
bjos-8641016	75	32	)	)	PUNCT
bjos-8641016	75	33	.	.	PUNCT
bjos-8641016	76	1	analysis	analysis	NOUN
bjos-8641016	76	2	by	by	ADP
bjos-8641016	76	3	sialometry	sialometry	NOUN
bjos-8641016	76	4	showed	show	VERB
bjos-8641016	76	5	reduced	reduce	VERB
bjos-8641016	76	6	salivary	salivary	ADJ
bjos-8641016	76	7	flow	flow	NOUN
bjos-8641016	76	8	as	as	ADV
bjos-8641016	76	9	early	early	ADV
bjos-8641016	76	10	as	as	ADP
bjos-8641016	76	11	10	10	NUM
bjos-8641016	76	12	days	day	NOUN
bjos-8641016	76	13	after	after	ADP
bjos-8641016	76	14	treatment	treatment	NOUN
bjos-8641016	76	15	.	.	PUNCT
bjos-8641016	77	1	this	this	DET
bjos-8641016	77	2	finding	finding	NOUN
bjos-8641016	77	3	indicates	indicate	VERB
bjos-8641016	77	4	the	the	DET
bjos-8641016	77	5	need	need	NOUN
bjos-8641016	77	6	for	for	ADP
bjos-8641016	77	7	complete	complete	ADJ
bjos-8641016	77	8	dental	dental	ADJ
bjos-8641016	77	9	follow	follow	NOUN
bjos-8641016	77	10	-	-	PUNCT
bjos-8641016	77	11	up	up	NOUN
bjos-8641016	77	12	of	of	ADP
bjos-8641016	77	13	these	these	DET
bjos-8641016	77	14	patients	patient	NOUN
bjos-8641016	77	15	since	since	SCONJ
bjos-8641016	77	16	the	the	DET
bjos-8641016	77	17	time	time	NOUN
bjos-8641016	77	18	of	of	ADP
bjos-8641016	77	19	admission	admission	NOUN
bjos-8641016	77	20	for	for	ADP
bjos-8641016	77	21	iodine	iodine	NOUN
bjos-8641016	77	22	131	131	NUM
bjos-8641016	77	23	treatment	treatment	NOUN
bjos-8641016	77	24	.	.	PUNCT
bjos-8641016	78	1	there	there	PRON
bjos-8641016	78	2	is	be	VERB
bjos-8641016	78	3	no	no	DET
bjos-8641016	78	4	consensus	consensus	NOUN
bjos-8641016	78	5	on	on	ADP
bjos-8641016	78	6	how	how	SCONJ
bjos-8641016	78	7	to	to	PART
bjos-8641016	78	8	prevent	prevent	VERB
bjos-8641016	78	9	adverse	adverse	ADJ
bjos-8641016	78	10	effects	effect	NOUN
bjos-8641016	78	11	of	of	ADP
bjos-8641016	78	12	ablation	ablation	NOUN
bjos-8641016	78	13	with	with	ADP
bjos-8641016	78	14	high	high	ADJ
bjos-8641016	78	15	doses	dose	NOUN
bjos-8641016	78	16	of	of	ADP
bjos-8641016	78	17	radioactive	radioactive	ADJ
bjos-8641016	78	18	iodine12	iodine12	NOUN
bjos-8641016	78	19	.	.	PUNCT
bjos-8641016	79	1	several	several	ADJ
bjos-8641016	79	2	protocols	protocol	NOUN
bjos-8641016	79	3	for	for	ADP
bjos-8641016	79	4	the	the	DET
bjos-8641016	79	5	prevention	prevention	NOUN
bjos-8641016	79	6	of	of	ADP
bjos-8641016	79	7	salivary	salivary	ADJ
bjos-8641016	79	8	gland	gland	NOUN
bjos-8641016	79	9	injury	injury	NOUN
bjos-8641016	79	10	are	be	AUX
bjos-8641016	79	11	used	use	VERB
bjos-8641016	79	12	.	.	PUNCT
bjos-8641016	80	1	the	the	DET
bjos-8641016	80	2	most	most	ADV
bjos-8641016	80	3	common	common	ADJ
bjos-8641016	80	4	recommendation	recommendation	NOUN
bjos-8641016	80	5	is	be	AUX
bjos-8641016	80	6	sucking	suck	VERB
bjos-8641016	80	7	lemon	lemon	NOUN
bjos-8641016	80	8	candies	candy	NOUN
bjos-8641016	80	9	or	or	CCONJ
bjos-8641016	80	10	ingestion	ingestion	NOUN
bjos-8641016	80	11	of	of	ADP
bjos-8641016	80	12	lemon	lemon	NOUN
bjos-8641016	80	13	juice	juice	NOUN
bjos-8641016	80	14	during	during	ADP
bjos-8641016	80	15	the	the	DET
bjos-8641016	80	16	period	period	NOUN
bjos-8641016	80	17	of	of	ADP
bjos-8641016	80	18	iodine	iodine	NOUN
bjos-8641016	80	19	131	131	NUM
bjos-8641016	80	20	treatment15	treatment15	NOUN
bjos-8641016	80	21	.	.	PUNCT
bjos-8641016	81	1	considering	consider	VERB
bjos-8641016	81	2	the	the	DET
bjos-8641016	81	3	definition	definition	NOUN
bjos-8641016	81	4	of	of	ADP
bjos-8641016	81	5	non	non	ADJ
bjos-8641016	81	6	-	-	ADJ
bjos-8641016	81	7	stimulated	stimulated	ADJ
bjos-8641016	81	8	and	and	CCONJ
bjos-8641016	81	9	stimulated	stimulate	VERB
bjos-8641016	81	10	hyposalivation	hyposalivation	NOUN
bjos-8641016	81	11	(	(	PUNCT
bjos-8641016	81	12	salivary	salivary	ADJ
bjos-8641016	81	13	flow	flow	NOUN
bjos-8641016	81	14	rate<0.1	rate<0.1	PROPN
bjos-8641016	81	15	ml	ml	NOUN
bjos-8641016	81	16	/	/	SYM
bjos-8641016	81	17	min	min	PROPN
bjos-8641016	81	18	and	and	CCONJ
bjos-8641016	81	19	<	<	X
bjos-8641016	81	20	0.7	0.7	NUM
bjos-8641016	81	21	ml	ml	NOUN
bjos-8641016	81	22	/	/	SYM
bjos-8641016	81	23	min	min	NOUN
bjos-8641016	81	24	,	,	PUNCT
bjos-8641016	81	25	respectively)14	respectively)14	NOUN
bjos-8641016	81	26	,	,	PUNCT
bjos-8641016	81	27	7	7	NUM
bjos-8641016	81	28	of	of	ADP
bjos-8641016	81	29	the	the	DET
bjos-8641016	81	30	studied	study	VERB
bjos-8641016	81	31	patients	patient	NOUN
bjos-8641016	81	32	had	have	VERB
bjos-8641016	81	33	non	non	ADJ
bjos-8641016	81	34	-	-	ADJ
bjos-8641016	81	35	stimulated	stimulated	ADJ
bjos-8641016	81	36	hyposalivation	hyposalivation	NOUN
bjos-8641016	81	37	and	and	CCONJ
bjos-8641016	81	38	18	18	NUM
bjos-8641016	81	39	patients	patient	NOUN
bjos-8641016	81	40	had	have	AUX
bjos-8641016	81	41	stimulated	stimulate	VERB
bjos-8641016	81	42	hyposalivation	hyposalivation	NOUN
bjos-8641016	81	43	at	at	ADP
bjos-8641016	81	44	baseline	baseline	NOUN
bjos-8641016	81	45	.	.	PUNCT
bjos-8641016	82	1	the	the	DET
bjos-8641016	82	2	prevention	prevention	NOUN
bjos-8641016	82	3	of	of	ADP
bjos-8641016	82	4	salivary	salivary	ADJ
bjos-8641016	82	5	gland	gland	NOUN
bjos-8641016	82	6	injuries	injury	NOUN
bjos-8641016	82	7	after	after	SCONJ
bjos-8641016	82	8	radioiodine	radioiodine	NOUN
bjos-8641016	82	9	ablation	ablation	NOUN
bjos-8641016	82	10	is	be	AUX
bjos-8641016	82	11	of	of	ADP
bjos-8641016	82	12	utmost	utmost	ADJ
bjos-8641016	82	13	importance	importance	NOUN
bjos-8641016	82	14	because	because	SCONJ
bjos-8641016	82	15	salivary	salivary	ADJ
bjos-8641016	82	16	gland	gland	NOUN
bjos-8641016	82	17	dysfunction	dysfunction	NOUN
bjos-8641016	82	18	as	as	ADP
bjos-8641016	82	19	an	an	DET
bjos-8641016	82	20	adverse	adverse	ADJ
bjos-8641016	82	21	effect	effect	NOUN
bjos-8641016	82	22	of	of	ADP
bjos-8641016	82	23	this	this	DET
bjos-8641016	82	24	therapy	therapy	NOUN
bjos-8641016	82	25	may	may	AUX
bjos-8641016	82	26	turn	turn	VERB
bjos-8641016	82	27	the	the	DET
bjos-8641016	82	28	patients	patient	NOUN
bjos-8641016	82	29	more	more	ADV
bjos-8641016	82	30	susceptible	susceptible	ADJ
bjos-8641016	82	31	to	to	ADP
bjos-8641016	82	32	carious	carious	ADJ
bjos-8641016	82	33	lesions	lesion	NOUN
bjos-8641016	82	34	and	and	CCONJ
bjos-8641016	82	35	periodontal	periodontal	ADJ
bjos-8641016	82	36	problems16	problems16	NOUN
bjos-8641016	82	37	.	.	PUNCT
bjos-8641016	83	1	the	the	DET
bjos-8641016	83	2	results	result	NOUN
bjos-8641016	83	3	of	of	ADP
bjos-8641016	83	4	this	this	DET
bjos-8641016	83	5	study	study	NOUN
bjos-8641016	83	6	suggest	suggest	VERB
bjos-8641016	83	7	that	that	SCONJ
bjos-8641016	83	8	changes	change	NOUN
bjos-8641016	83	9	in	in	ADP
bjos-8641016	83	10	salivary	salivary	ADJ
bjos-8641016	83	11	flow	flow	NOUN
bjos-8641016	83	12	resulting	result	VERB
bjos-8641016	83	13	from	from	ADP
bjos-8641016	83	14	radioiodine	radioiodine	NOUN
bjos-8641016	83	15	therapy	therapy	NOUN
bjos-8641016	83	16	are	be	AUX
bjos-8641016	83	17	more	more	ADV
bjos-8641016	83	18	pronounced	pronounced	ADJ
bjos-8641016	83	19	during	during	ADP
bjos-8641016	83	20	the	the	DET
bjos-8641016	83	21	first	first	ADJ
bjos-8641016	83	22	weeks	week	NOUN
bjos-8641016	83	23	after	after	ADP
bjos-8641016	83	24	treatment	treatment	NOUN
bjos-8641016	83	25	and	and	CCONJ
bjos-8641016	83	26	it	it	PRON
bjos-8641016	83	27	seems	seem	VERB
bjos-8641016	83	28	to	to	PART
bjos-8641016	83	29	retreat	retreat	VERB
bjos-8641016	83	30	after	after	ADP
bjos-8641016	83	31	3	3	NUM
bjos-8641016	83	32	months	month	NOUN
bjos-8641016	83	33	.	.	PUNCT
bjos-8641016	84	1	however	however	ADV
bjos-8641016	84	2	,	,	PUNCT
bjos-8641016	84	3	further	further	ADJ
bjos-8641016	84	4	clinical	clinical	ADJ
bjos-8641016	84	5	studies	study	NOUN
bjos-8641016	84	6	are	be	AUX
bjos-8641016	84	7	needed	need	VERB
bjos-8641016	84	8	for	for	ADP
bjos-8641016	84	9	evaluating	evaluate	VERB
bjos-8641016	84	10	qualitative	qualitative	ADJ
bjos-8641016	84	11	changes	change	NOUN
bjos-8641016	84	12	of	of	ADP
bjos-8641016	84	13	salivary	salivary	ADJ
bjos-8641016	84	14	composition	composition	NOUN
bjos-8641016	84	15	in	in	ADP
bjos-8641016	84	16	patients	patient	NOUN
bjos-8641016	84	17	undergoing	undergo	VERB
bjos-8641016	84	18	radioiodine	radioiodine	NOUN
bjos-8641016	84	19	therapy	therapy	NOUN
bjos-8641016	84	20	.	.	PUNCT
bjos-8641016	85	1	after	after	ADP
bjos-8641016	85	2	radioiodine	radioiodine	NOUN
bjos-8641016	85	3	therapy	therapy	NOUN
bjos-8641016	85	4	,	,	PUNCT
bjos-8641016	85	5	atients	atient	NOUN
bjos-8641016	85	6	require	require	VERB
bjos-8641016	85	7	efficient	efficient	ADJ
bjos-8641016	85	8	measures	measure	NOUN
bjos-8641016	85	9	to	to	PART
bjos-8641016	85	10	prevent	prevent	VERB
bjos-8641016	85	11	or	or	CCONJ
bjos-8641016	85	12	reduce	reduce	VERB
bjos-8641016	85	13	salivary	salivary	ADJ
bjos-8641016	85	14	gland	gland	NOUN
bjos-8641016	85	15	dysfunction	dysfunction	NOUN
bjos-8641016	85	16	in	in	ADP
bjos-8641016	85	17	order	order	NOUN
bjos-8641016	85	18	to	to	PART
bjos-8641016	85	19	improve	improve	VERB
bjos-8641016	85	20	their	their	PRON
bjos-8641016	85	21	quality	quality	NOUN
bjos-8641016	85	22	of	of	ADP
bjos-8641016	85	23	life	life	NOUN
bjos-8641016	85	24	.	.	PUNCT
bjos-8641016	86	1	acknowledgements	acknowledgement	NOUN
bjos-8641016	86	2	we	we	PRON
bjos-8641016	86	3	thank	thank	VERB
bjos-8641016	86	4	capes/	capes/	NUM
bjos-8641016	86	5	education	education	NOUN
bjos-8641016	86	6	and	and	CCONJ
bjos-8641016	86	7	culture	culture	NOUN
bjos-8641016	86	8	government	government	NOUN
bjos-8641016	86	9	for	for	ADP
bjos-8641016	86	10	the	the	DET
bjos-8641016	86	11	master	master	NOUN
bjos-8641016	86	12	’s	’s	PART
bjos-8641016	86	13	fellowship	fellowship	NOUN
bjos-8641016	86	14	granted	grant	VERB
bjos-8641016	86	15	to	to	ADP
bjos-8641016	86	16	anna	anna	PROPN
bjos-8641016	86	17	clara	clara	PROPN
bjos-8641016	86	18	fontes	fontes	PROPN
bjos-8641016	86	19	vieira	vieira	PROPN
bjos-8641016	86	20	.	.	PUNCT
bjos-8641016	87	1	we	we	PRON
bjos-8641016	87	2	also	also	ADV
bjos-8641016	87	3	thank	thank	VERB
bjos-8641016	87	4	fapema	fapema	NOUN
bjos-8641016	87	5	for	for	ADP
bjos-8641016	87	6	publishing	publish	VERB
bjos-8641016	87	7	support	support	NOUN
bjos-8641016	87	8	and	and	CCONJ
bjos-8641016	87	9	stimulated	stimulate	VERB
bjos-8641016	87	10	salivary	salivary	ADJ
bjos-8641016	87	11	flow	flow	NOUN
bjos-8641016	87	12	1st	1st	ADJ
bjos-8641016	87	13	evaluation	evaluation	NOUN
bjos-8641016	87	14	2nd	2nd	ADJ
bjos-8641016	87	15	evaluation	evaluation	NOUN
bjos-8641016	87	16	mean	mean	NOUN
bjos-8641016	87	17	sd	sd	AUX
bjos-8641016	87	18	mean	mean	VERB
bjos-8641016	87	19	sd	sd	ADP
bjos-8641016	87	20	t	t	PROPN
bjos-8641016	87	21	p	p	PROPN
bjos-8641016	87	22	1.5808	1.5808	NUM
bjos-8641016	87	23	0.877	0.877	NUM
bjos-8641016	87	24	1.4144	1.4144	NUM
bjos-8641016	87	25	0.9452	0.9452	NUM
bjos-8641016	87	26	2.780	2.780	NUM
bjos-8641016	87	27	0.010	0.010	NUM
bjos-8641016	87	28	1st	1st	ADJ
bjos-8641016	87	29	evaluation	evaluation	NOUN
bjos-8641016	87	30	3rd	3rd	ADJ
bjos-8641016	87	31	evaluation	evaluation	NOUN
bjos-8641016	87	32	mean	mean	NOUN
bjos-8641016	87	33	sd	sd	AUX
bjos-8641016	87	34	mean	mean	VERB
bjos-8641016	87	35	sd	sd	ADP
bjos-8641016	87	36	t	t	PROPN
bjos-8641016	87	37	p	p	PROPN
bjos-8641016	87	38	1.5808	1.5808	NUM
bjos-8641016	87	39	0.877	0.877	NUM
bjos-8641016	87	40	1.6864	1.6864	NUM
bjos-8641016	87	41	1.0774	1.0774	NUM
bjos-8641016	87	42	-0.815	-0.815	NOUN
bjos-8641016	87	43	0.423	0.423	NUM
bjos-8641016	87	44	2nd	2nd	ADJ
bjos-8641016	87	45	evaluation	evaluation	NOUN
bjos-8641016	87	46	3rd	3rd	ADJ
bjos-8641016	87	47	evaluation	evaluation	NOUN
bjos-8641016	87	48	mean	mean	NOUN
bjos-8641016	87	49	sd	sd	AUX
bjos-8641016	87	50	mean	mean	VERB
bjos-8641016	87	51	sd	sd	ADP
bjos-8641016	87	52	t	t	PROPN
bjos-8641016	87	53	p	p	PROPN
bjos-8641016	87	54	1.4144	1.4144	NUM
bjos-8641016	87	55	0.9452	0.9452	NUM
bjos-8641016	87	56	1.6864	1.6864	NUM
bjos-8641016	87	57	1.0774	1.0774	NUM
bjos-8641016	87	58	-1.992	-1.992	NOUN
bjos-8641016	87	59	0.058	0.058	NUM
bjos-8641016	87	60	table	table	NOUN
bjos-8641016	87	61	2	2	NUM
bjos-8641016	87	62	.	.	PUNCT
bjos-8641016	87	63	comparison	comparison	NOUN
bjos-8641016	87	64	of	of	ADP
bjos-8641016	87	65	stimulated	stimulate	VERB
bjos-8641016	87	66	salivary	salivary	ADJ
bjos-8641016	87	67	flow	flow	NOUN
bjos-8641016	87	68	before	before	ADP
bjos-8641016	87	69	radioiodine	radioiodine	NOUN
bjos-8641016	87	70	therapy	therapy	NOUN
bjos-8641016	87	71	(	(	PUNCT
bjos-8641016	87	72	1st	1st	ADJ
bjos-8641016	87	73	evaluation	evaluation	NOUN
bjos-8641016	87	74	)	)	PUNCT
bjos-8641016	87	75	,	,	PUNCT
bjos-8641016	87	76	10	10	NUM
bjos-8641016	87	77	days	day	NOUN
bjos-8641016	87	78	(	(	PUNCT
bjos-8641016	87	79	2nd	2nd	ADJ
bjos-8641016	87	80	evaluation	evaluation	NOUN
bjos-8641016	87	81	)	)	PUNCT
bjos-8641016	87	82	and	and	CCONJ
bjos-8641016	87	83	3	3	NUM
bjos-8641016	87	84	months	month	NOUN
bjos-8641016	87	85	(	(	PUNCT
bjos-8641016	87	86	3rd	3rd	ADJ
bjos-8641016	87	87	evaluation	evaluation	NOUN
bjos-8641016	87	88	)	)	PUNCT
bjos-8641016	87	89	after	after	ADP
bjos-8641016	87	90	therapy	therapy	NOUN
bjos-8641016	87	91	in	in	ADP
bjos-8641016	87	92	25	25	NUM
bjos-8641016	87	93	patients	patient	NOUN
bjos-8641016	87	94	submitted	submit	VERB
bjos-8641016	87	95	to	to	ADP
bjos-8641016	87	96	thyroidectomy	thyroidectomy	NOUN
bjos-8641016	87	97	*	*	PUNCT
bjos-8641016	87	98	.	.	PUNCT
bjos-8641016	88	1	results	result	NOUN
bjos-8641016	88	2	are	be	AUX
bjos-8641016	88	3	reported	report	VERB
bjos-8641016	88	4	as	as	ADP
bjos-8641016	88	5	mean	mean	ADJ
bjos-8641016	88	6	and	and	CCONJ
bjos-8641016	88	7	standard	standard	ADJ
bjos-8641016	88	8	deviation	deviation	NOUN
bjos-8641016	88	9	(	(	PUNCT
bjos-8641016	88	10	sd	sd	NOUN
bjos-8641016	88	11	)	)	PUNCT
bjos-8641016	88	12	.	.	PUNCT
bjos-8641016	89	1	p<0.05	p<0.05	NOUN
bjos-8641016	89	2	(	(	PUNCT
bjos-8641016	89	3	paired	pair	VERB
bjos-8641016	89	4	t	t	NOUN
bjos-8641016	89	5	-	-	PUNCT
bjos-8641016	89	6	test	test	NOUN
bjos-8641016	89	7	)	)	PUNCT
bjos-8641016	89	8	.	.	PUNCT
bjos-8641016	90	1	*	*	PUNCT
bjos-8641016	90	2	only	only	ADV
bjos-8641016	90	3	25	25	NUM
bjos-8641016	90	4	participants	participant	NOUN
bjos-8641016	90	5	were	be	AUX
bjos-8641016	90	6	submitted	submit	VERB
bjos-8641016	90	7	to	to	PART
bjos-8641016	90	8	sialometry	sialometry	NOUN
bjos-8641016	90	9	3	3	NUM
bjos-8641016	90	10	months	month	NOUN
bjos-8641016	90	11	after	after	ADP
bjos-8641016	90	12	the	the	DET
bjos-8641016	90	13	administration	administration	NOUN
bjos-8641016	90	14	of	of	ADP
bjos-8641016	90	15	iodine	iodine	NOUN
bjos-8641016	90	16	131	131	NUM
bjos-8641016	90	17	.	.	PUNCT
bjos-8641016	91	1	profile	profile	NOUN
bjos-8641016	91	2	of	of	ADP
bjos-8641016	91	3	salivary	salivary	ADJ
bjos-8641016	91	4	gland	gland	NOUN
bjos-8641016	91	5	flow	flow	NOUN
bjos-8641016	91	6	dysfunctions	dysfunction	NOUN
bjos-8641016	91	7	in	in	ADP
bjos-8641016	91	8	patients	patient	NOUN
bjos-8641016	91	9	with	with	ADP
bjos-8641016	91	10	differentiated	differentiated	ADJ
bjos-8641016	91	11	thyroid	thyroid	NOUN
bjos-8641016	91	12	carcinoma	carcinoma	NOUN
bjos-8641016	91	13	submitted	submit	VERB
bjos-8641016	91	14	to	to	PART
bjos-8641016	91	15	radioiodine	radioiodine	VERB
bjos-8641016	91	16	therapy	therapy	NOUN
bjos-8641016	91	17	braz	braz	PROPN
bjos-8641016	91	18	j	j	PROPN
bjos-8641016	91	19	oral	oral	PROPN
bjos-8641016	91	20	sci	sci	PROPN
bjos-8641016	91	21	.	.	PUNCT
bjos-8641016	92	1	12(3):169	12(3):169	NUM
bjos-8641016	92	2	-	-	SYM
bjos-8641016	92	3	172	172	NUM
bjos-8641016	92	4	172172172172172	172172172172172	NUM
bjos-8641016	92	5	dr	dr	PROPN
bjos-8641016	92	6	.	.	PROPN
bjos-8641016	92	7	ibrahim	ibrahim	PROPN
bjos-8641016	92	8	assub	assub	PROPN
bjos-8641016	92	9	and	and	CCONJ
bjos-8641016	92	10	the	the	DET
bjos-8641016	92	11	nuclear	nuclear	ADJ
bjos-8641016	92	12	medicine	medicine	NOUN
bjos-8641016	92	13	clinic	clinic	NOUN
bjos-8641016	92	14	of	of	ADP
bjos-8641016	92	15	maranhão	maranhão	NOUN
bjos-8641016	92	16	for	for	ADP
bjos-8641016	92	17	providing	provide	VERB
bjos-8641016	92	18	the	the	DET
bjos-8641016	92	19	physical	physical	ADJ
bjos-8641016	92	20	space	space	NOUN
bjos-8641016	92	21	for	for	ADP
bjos-8641016	92	22	sample	sample	NOUN
bjos-8641016	92	23	collection	collection	NOUN
bjos-8641016	92	24	and	and	CCONJ
bjos-8641016	92	25	for	for	ADP
bjos-8641016	92	26	the	the	DET
bjos-8641016	92	27	interview	interview	NOUN
bjos-8641016	92	28	with	with	ADP
bjos-8641016	92	29	the	the	DET
bjos-8641016	92	30	volunteers	volunteer	NOUN
bjos-8641016	92	31	of	of	ADP
bjos-8641016	92	32	the	the	DET
bjos-8641016	92	33	study	study	NOUN
bjos-8641016	92	34	.	.	PUNCT
bjos-8641016	93	1	references	reference	NOUN
bjos-8641016	93	2	1	1	NUM
bjos-8641016	93	3	.	.	PUNCT
bjos-8641016	93	4	ward	ward	PROPN
bjos-8641016	93	5	ls	ls	PROPN
bjos-8641016	93	6	,	,	PUNCT
bjos-8641016	93	7	assumpção	assumpção	PROPN
bjos-8641016	93	8	lv	lv	PROPN
bjos-8641016	93	9	.	.	PROPN
bjos-8641016	93	10	thyroid	thyroid	NOUN
bjos-8641016	93	11	cancer	cancer	NOUN
bjos-8641016	93	12	:	:	PUNCT
bjos-8641016	93	13	prognostic	prognostic	ADJ
bjos-8641016	93	14	factors	factor	NOUN
bjos-8641016	93	15	and	and	CCONJ
bjos-8641016	93	16	treatment	treatment	NOUN
bjos-8641016	93	17	.	.	PUNCT
bjos-8641016	94	1	arq	arq	PROPN
bjos-8641016	94	2	bras	bras	PROPN
bjos-8641016	94	3	endocrinol	endocrinol	NOUN
bjos-8641016	94	4	metabol	metabol	NOUN
bjos-8641016	94	5	.	.	PUNCT
bjos-8641016	95	1	2004	2004	NUM
bjos-8641016	95	2	;	;	PUNCT
bjos-8641016	95	3	48	48	NUM
bjos-8641016	95	4	:	:	SYM
bjos-8641016	95	5	126	126	NUM
bjos-8641016	95	6	-	-	SYM
bjos-8641016	95	7	36	36	NUM
bjos-8641016	95	8	.	.	PUNCT
bjos-8641016	96	1	2	2	X
bjos-8641016	96	2	.	.	X
bjos-8641016	96	3	van	van	PROPN
bjos-8641016	96	4	nostrand	nostrand	PROPN
bjos-8641016	96	5	d.	d.	PROPN
bjos-8641016	96	6	sialoadenitis	sialoadeniti	VERB
bjos-8641016	96	7	secondary	secondary	ADJ
bjos-8641016	96	8	to	to	ADP
bjos-8641016	96	9	131i	131i	NUM
bjos-8641016	96	10	therapy	therapy	NOUN
bjos-8641016	96	11	for	for	ADP
bjos-8641016	96	12	well	well	ADV
bjos-8641016	96	13	-	-	PUNCT
bjos-8641016	96	14	differentiated	differentiate	VERB
bjos-8641016	96	15	thyroid	thyroid	NOUN
bjos-8641016	96	16	cancer	cancer	NOUN
bjos-8641016	96	17	.	.	PUNCT
bjos-8641016	97	1	oral	oral	ADJ
bjos-8641016	97	2	dis	dis	PROPN
bjos-8641016	97	3	.	.	PUNCT
bjos-8641016	98	1	2011	2011	NUM
bjos-8641016	98	2	;	;	PUNCT
bjos-8641016	98	3	17	17	NUM
bjos-8641016	98	4	:	:	SYM
bjos-8641016	98	5	154	154	NUM
bjos-8641016	98	6	-	-	SYM
bjos-8641016	98	7	61	61	NUM
bjos-8641016	98	8	.	.	PUNCT
bjos-8641016	99	1	3	3	X
bjos-8641016	99	2	.	.	X
bjos-8641016	99	3	solans	solans	PROPN
bjos-8641016	99	4	r	r	PROPN
bjos-8641016	99	5	,	,	PUNCT
bjos-8641016	99	6	bosch	bosch	PROPN
bjos-8641016	99	7	ja	ja	PROPN
bjos-8641016	99	8	,	,	PUNCT
bjos-8641016	99	9	galofré	galofré	NOUN
bjos-8641016	99	10	p	p	PROPN
bjos-8641016	99	11	,	,	PUNCT
bjos-8641016	99	12	porta	porta	PROPN
bjos-8641016	99	13	f	f	X
bjos-8641016	99	14	,	,	PUNCT
bjos-8641016	99	15	roselló	roselló	PROPN
bjos-8641016	99	16	j	j	PROPN
bjos-8641016	99	17	,	,	PUNCT
bjos-8641016	99	18	selva	selva	PROPN
bjos-8641016	99	19	-	-	PUNCT
bjos-8641016	99	20	o’callagan	o’callagan	VERB
bjos-8641016	99	21	a	a	PRON
bjos-8641016	99	22	,	,	PUNCT
bjos-8641016	99	23	et	et	PROPN
bjos-8641016	99	24	al	al	PROPN
bjos-8641016	99	25	.	.	PROPN
bjos-8641016	99	26	salivary	salivary	VERB
bjos-8641016	99	27	and	and	CCONJ
bjos-8641016	99	28	lacrimal	lacrimal	ADJ
bjos-8641016	99	29	gland	gland	NOUN
bjos-8641016	99	30	dysfunction	dysfunction	NOUN
bjos-8641016	99	31	(	(	PUNCT
bjos-8641016	99	32	sicca	sicca	NOUN
bjos-8641016	99	33	syndrome	syndrome	PROPN
bjos-8641016	99	34	)	)	PUNCT
bjos-8641016	99	35	after	after	ADP
bjos-8641016	99	36	radioiodine	radioiodine	NOUN
bjos-8641016	99	37	therapy	therapy	NOUN
bjos-8641016	99	38	.	.	PUNCT
bjos-8641016	100	1	j	j	PROPN
bjos-8641016	100	2	nucl	nucl	PROPN
bjos-8641016	100	3	med	med	PROPN
bjos-8641016	100	4	.	.	PUNCT
bjos-8641016	100	5	2001	2001	NUM
bjos-8641016	100	6	;	;	PUNCT
bjos-8641016	100	7	42	42	NUM
bjos-8641016	100	8	:	:	PUNCT
bjos-8641016	100	9	738	738	NUM
bjos-8641016	100	10	-	-	SYM
bjos-8641016	100	11	43	43	NUM
bjos-8641016	100	12	.	.	PUNCT
bjos-8641016	101	1	4	4	X
bjos-8641016	101	2	.	.	X
bjos-8641016	101	3	almeida	almeida	PROPN
bjos-8641016	101	4	jp	jp	PROPN
bjos-8641016	101	5	,	,	PUNCT
bjos-8641016	101	6	sanabria	sanabria	PROPN
bjos-8641016	101	7	ae	ae	PROPN
bjos-8641016	101	8	,	,	PUNCT
bjos-8641016	101	9	lima	lima	PROPN
bjos-8641016	101	10	en	en	X
bjos-8641016	101	11	,	,	PUNCT
bjos-8641016	101	12	kowalski	kowalski	PROPN
bjos-8641016	101	13	lp	lp	PROPN
bjos-8641016	101	14	.	.	PUNCT
bjos-8641016	102	1	late	late	ADJ
bjos-8641016	102	2	side	side	NOUN
bjos-8641016	102	3	effects	effect	NOUN
bjos-8641016	102	4	of	of	ADP
bjos-8641016	102	5	radioactive	radioactive	ADJ
bjos-8641016	102	6	iodine	iodine	NOUN
bjos-8641016	102	7	on	on	ADP
bjos-8641016	102	8	salivary	salivary	ADJ
bjos-8641016	102	9	gland	gland	NOUN
bjos-8641016	102	10	function	function	NOUN
bjos-8641016	102	11	in	in	ADP
bjos-8641016	102	12	patients	patient	NOUN
bjos-8641016	102	13	with	with	ADP
bjos-8641016	102	14	thyroid	thyroid	NOUN
bjos-8641016	102	15	cancer	cancer	NOUN
bjos-8641016	102	16	.	.	PUNCT
bjos-8641016	103	1	head	head	NOUN
bjos-8641016	103	2	neck	neck	NOUN
bjos-8641016	103	3	.	.	PUNCT
bjos-8641016	104	1	2011	2011	NUM
bjos-8641016	104	2	;	;	PUNCT
bjos-8641016	104	3	33	33	NUM
bjos-8641016	104	4	:	:	PUNCT
bjos-8641016	104	5	686	686	NUM
bjos-8641016	104	6	-	-	SYM
bjos-8641016	104	7	90	90	NUM
bjos-8641016	104	8	.	.	PUNCT
bjos-8641016	105	1	5	5	NUM
bjos-8641016	105	2	.	.	PUNCT
bjos-8641016	106	1	liu	liu	PROPN
bjos-8641016	106	2	b	b	PROPN
bjos-8641016	106	3	,	,	PUNCT
bjos-8641016	106	4	kuang	kuang	PROPN
bjos-8641016	106	5	a	a	PROPN
bjos-8641016	106	6	,	,	PUNCT
bjos-8641016	106	7	huang	huang	PROPN
bjos-8641016	106	8	r	r	PROPN
bjos-8641016	106	9	,	,	PUNCT
bjos-8641016	106	10	zhao	zhao	PROPN
bjos-8641016	106	11	z	z	PROPN
bjos-8641016	106	12	,	,	PUNCT
bjos-8641016	106	13	zeng	zeng	PROPN
bjos-8641016	106	14	y	y	PROPN
bjos-8641016	106	15	,	,	PUNCT
bjos-8641016	106	16	wang	wang	PROPN
bjos-8641016	106	17	j	j	PROPN
bjos-8641016	106	18	,	,	PUNCT
bjos-8641016	106	19	tian	tian	PROPN
bjos-8641016	106	20	r.	r.	PROPN
bjos-8641016	106	21	influence	influence	NOUN
bjos-8641016	106	22	of	of	ADP
bjos-8641016	106	23	vitamin	vitamin	NOUN
bjos-8641016	106	24	c	c	NOUN
bjos-8641016	106	25	on	on	ADP
bjos-8641016	106	26	salivary	salivary	ADJ
bjos-8641016	106	27	absorbed	absorb	VERB
bjos-8641016	106	28	dose	dose	NOUN
bjos-8641016	106	29	of	of	ADP
bjos-8641016	106	30	131i	131i	PROPN
bjos-8641016	106	31	in	in	ADP
bjos-8641016	106	32	thyroid	thyroid	NOUN
bjos-8641016	106	33	cancer	cancer	NOUN
bjos-8641016	106	34	patients	patient	NOUN
bjos-8641016	106	35	:	:	PUNCT
bjos-8641016	106	36	a	a	DET
bjos-8641016	106	37	prospective	prospective	ADJ
bjos-8641016	106	38	,	,	PUNCT
bjos-8641016	106	39	randomized	randomize	VERB
bjos-8641016	106	40	,	,	PUNCT
bjos-8641016	106	41	single	single	ADJ
bjos-8641016	106	42	-	-	PUNCT
bjos-8641016	106	43	blind	blind	ADJ
bjos-8641016	106	44	,	,	PUNCT
bjos-8641016	106	45	controlled	control	VERB
bjos-8641016	106	46	trial	trial	NOUN
bjos-8641016	106	47	.	.	PUNCT
bjos-8641016	107	1	j	j	PROPN
bjos-8641016	107	2	nucl	nucl	PROPN
bjos-8641016	107	3	med	med	PROPN
bjos-8641016	107	4	.	.	PUNCT
bjos-8641016	107	5	2010	2010	NUM
bjos-8641016	107	6	;	;	PUNCT
bjos-8641016	107	7	51	51	NUM
bjos-8641016	107	8	:	:	SYM
bjos-8641016	107	9	618	618	NUM
bjos-8641016	107	10	-	-	SYM
bjos-8641016	107	11	23	23	NUM
bjos-8641016	107	12	.	.	PUNCT
bjos-8641016	108	1	6	6	NUM
bjos-8641016	108	2	.	.	X
bjos-8641016	108	3	jentzen	jentzen	PROPN
bjos-8641016	108	4	w	w	PROPN
bjos-8641016	108	5	,	,	PUNCT
bjos-8641016	108	6	balschuweit	balschuweit	PROPN
bjos-8641016	108	7	d	d	PROPN
bjos-8641016	108	8	,	,	PUNCT
bjos-8641016	108	9	schmitz	schmitz	PROPN
bjos-8641016	108	10	j	j	PROPN
bjos-8641016	108	11	,	,	PUNCT
bjos-8641016	108	12	freudenberg	freudenberg	PROPN
bjos-8641016	108	13	l	l	PROPN
bjos-8641016	108	14	,	,	PUNCT
bjos-8641016	108	15	eising	eise	VERB
bjos-8641016	108	16	e	e	NOUN
bjos-8641016	108	17	,	,	PUNCT
bjos-8641016	108	18	hilbel	hilbel	PROPN
bjos-8641016	108	19	t	t	PROPN
bjos-8641016	108	20	,	,	PUNCT
bjos-8641016	108	21	et	et	PROPN
bjos-8641016	108	22	al	al	PROPN
bjos-8641016	108	23	.	.	PUNCT
bjos-8641016	109	1	the	the	DET
bjos-8641016	109	2	influence	influence	NOUN
bjos-8641016	109	3	of	of	ADP
bjos-8641016	109	4	saliva	saliva	NOUN
bjos-8641016	109	5	flow	flow	NOUN
bjos-8641016	109	6	stimulation	stimulation	NOUN
bjos-8641016	109	7	on	on	ADP
bjos-8641016	109	8	the	the	DET
bjos-8641016	109	9	absorbed	absorb	VERB
bjos-8641016	109	10	radiation	radiation	NOUN
bjos-8641016	109	11	dose	dose	VERB
bjos-8641016	109	12	to	to	ADP
bjos-8641016	109	13	the	the	DET
bjos-8641016	109	14	salivary	salivary	ADJ
bjos-8641016	109	15	glands	gland	NOUN
bjos-8641016	109	16	during	during	ADP
bjos-8641016	109	17	radioiodine	radioiodine	NOUN
bjos-8641016	109	18	therapy	therapy	NOUN
bjos-8641016	109	19	of	of	ADP
bjos-8641016	109	20	thyroid	thyroid	NOUN
bjos-8641016	109	21	cancer	cancer	NOUN
bjos-8641016	109	22	using	use	VERB
bjos-8641016	109	23	(	(	PUNCT
bjos-8641016	109	24	124)i	124)i	NUM
bjos-8641016	109	25	pet(/ct	pet(/ct	NOUN
bjos-8641016	109	26	)	)	PUNCT
bjos-8641016	109	27	imaging	imaging	NOUN
bjos-8641016	109	28	.	.	PUNCT
bjos-8641016	110	1	eur	eur	PROPN
bjos-8641016	110	2	j	j	PROPN
bjos-8641016	110	3	nucl	nucl	PROPN
bjos-8641016	110	4	med	me	VERB
bjos-8641016	110	5	mol	mol	ADP
bjos-8641016	110	6	imaging	imaging	NOUN
bjos-8641016	110	7	.	.	PUNCT
bjos-8641016	111	1	2010	2010	NUM
bjos-8641016	111	2	;	;	PUNCT
bjos-8641016	111	3	37	37	NUM
bjos-8641016	111	4	:	:	SYM
bjos-8641016	111	5	2298	2298	NUM
bjos-8641016	111	6	-	-	SYM
bjos-8641016	111	7	306	306	NUM
bjos-8641016	111	8	.	.	PUNCT
bjos-8641016	112	1	7	7	X
bjos-8641016	112	2	.	.	X
bjos-8641016	112	3	aframian	aframian	PROPN
bjos-8641016	112	4	dj	dj	PROPN
bjos-8641016	112	5	,	,	PUNCT
bjos-8641016	112	6	helcer	helcer	PROPN
bjos-8641016	112	7	m	m	PROPN
bjos-8641016	112	8	,	,	PUNCT
bjos-8641016	112	9	livni	livni	PROPN
bjos-8641016	112	10	d	d	PROPN
bjos-8641016	112	11	,	,	PUNCT
bjos-8641016	112	12	markitziu	markitziu	PROPN
bjos-8641016	112	13	a.	a.	NOUN
bjos-8641016	112	14	pilocarpine	pilocarpine	PROPN
bjos-8641016	112	15	for	for	ADP
bjos-8641016	112	16	the	the	DET
bjos-8641016	112	17	treatment	treatment	NOUN
bjos-8641016	112	18	of	of	ADP
bjos-8641016	112	19	salivary	salivary	ADJ
bjos-8641016	112	20	glands	gland	NOUN
bjos-8641016	112	21	’	'	PUNCT
bjos-8641016	112	22	impairment	impairment	NOUN
bjos-8641016	112	23	caused	cause	VERB
bjos-8641016	112	24	by	by	ADP
bjos-8641016	112	25	radioiodine	radioiodine	NOUN
bjos-8641016	112	26	therapy	therapy	NOUN
bjos-8641016	112	27	for	for	ADP
bjos-8641016	112	28	thyroid	thyroid	NOUN
bjos-8641016	112	29	cancer	cancer	NOUN
bjos-8641016	112	30	.	.	PUNCT
bjos-8641016	113	1	oral	oral	ADJ
bjos-8641016	113	2	dis	dis	PROPN
bjos-8641016	113	3	.	.	PUNCT
bjos-8641016	114	1	2006	2006	NUM
bjos-8641016	114	2	;	;	PUNCT
bjos-8641016	114	3	12	12	NUM
bjos-8641016	114	4	:	:	SYM
bjos-8641016	114	5	297	297	NUM
bjos-8641016	114	6	-	-	SYM
bjos-8641016	114	7	300	300	NUM
bjos-8641016	114	8	.	.	NOUN
bjos-8641016	114	9	8	8	NUM
bjos-8641016	114	10	.	.	PUNCT
bjos-8641016	114	11	silberstein	silberstein	PROPN
bjos-8641016	114	12	eb	eb	PROPN
bjos-8641016	114	13	.	.	PUNCT
bjos-8641016	115	1	reducing	reduce	VERB
bjos-8641016	115	2	the	the	DET
bjos-8641016	115	3	incidence	incidence	NOUN
bjos-8641016	115	4	of	of	ADP
bjos-8641016	115	5	131i	131i	PROPN
bjos-8641016	115	6	-	-	PUNCT
bjos-8641016	115	7	induced	induce	VERB
bjos-8641016	115	8	sialadenitis	sialadenitis	NOUN
bjos-8641016	115	9	:	:	PUNCT
bjos-8641016	115	10	the	the	DET
bjos-8641016	115	11	role	role	NOUN
bjos-8641016	115	12	of	of	ADP
bjos-8641016	115	13	pilocarpine	pilocarpine	NOUN
bjos-8641016	115	14	.	.	PUNCT
bjos-8641016	116	1	j	j	PROPN
bjos-8641016	116	2	nucl	nucl	PROPN
bjos-8641016	116	3	med	med	PROPN
bjos-8641016	116	4	.	.	PROPN
bjos-8641016	116	5	2008	2008	NUM
bjos-8641016	116	6	;	;	PUNCT
bjos-8641016	116	7	49	49	NUM
bjos-8641016	116	8	:	:	PUNCT
bjos-8641016	116	9	546	546	NUM
bjos-8641016	116	10	-	-	SYM
bjos-8641016	116	11	9	9	NUM
bjos-8641016	116	12	.	.	NOUN
bjos-8641016	117	1	9	9	NUM
bjos-8641016	117	2	.	.	X
bjos-8641016	117	3	grewal	grewal	PROPN
bjos-8641016	117	4	rk	rk	PROPN
bjos-8641016	117	5	,	,	PUNCT
bjos-8641016	117	6	larson	larson	PROPN
bjos-8641016	117	7	sm	sm	PROPN
bjos-8641016	117	8	,	,	PUNCT
bjos-8641016	117	9	pentlow	pentlow	PROPN
bjos-8641016	117	10	ce	ce	PROPN
bjos-8641016	117	11	,	,	PUNCT
bjos-8641016	117	12	pentlow	pentlow	PROPN
bjos-8641016	117	13	ks	ks	PROPN
bjos-8641016	117	14	,	,	PUNCT
bjos-8641016	117	15	gonen	gonen	PROPN
bjos-8641016	117	16	m	m	PROPN
bjos-8641016	117	17	,	,	PUNCT
bjos-8641016	117	18	qualey	qualey	PROPN
bjos-8641016	117	19	r	r	PROPN
bjos-8641016	117	20	,	,	PUNCT
bjos-8641016	117	21	et	et	PROPN
bjos-8641016	117	22	al	al	PROPN
bjos-8641016	117	23	.	.	PROPN
bjos-8641016	118	1	salivary	salivary	PROPN
bjos-8641016	118	2	gland	gland	NOUN
bjos-8641016	118	3	side	side	NOUN
bjos-8641016	118	4	effects	effect	NOUN
bjos-8641016	118	5	commonly	commonly	ADV
bjos-8641016	118	6	develop	develop	VERB
bjos-8641016	118	7	several	several	ADJ
bjos-8641016	118	8	weeks	week	NOUN
bjos-8641016	118	9	after	after	ADP
bjos-8641016	118	10	initial	initial	ADJ
bjos-8641016	118	11	radioactive	radioactive	ADJ
bjos-8641016	118	12	iodine	iodine	NOUN
bjos-8641016	118	13	ablation	ablation	NOUN
bjos-8641016	118	14	.	.	PUNCT
bjos-8641016	119	1	j	j	PROPN
bjos-8641016	119	2	nucl	nucl	PROPN
bjos-8641016	119	3	med	med	PROPN
bjos-8641016	119	4	.	.	PUNCT
bjos-8641016	119	5	2009	2009	NUM
bjos-8641016	119	6	;	;	PUNCT
bjos-8641016	119	7	50	50	NUM
bjos-8641016	119	8	:	:	SYM
bjos-8641016	119	9	1605	1605	NUM
bjos-8641016	119	10	-	-	SYM
bjos-8641016	119	11	10	10	NUM
bjos-8641016	119	12	.	.	PUNCT
bjos-8641016	120	1	10	10	NUM
bjos-8641016	120	2	.	.	PUNCT
bjos-8641016	121	1	amenábar	amenábar	PROPN
bjos-8641016	121	2	j	j	PROPN
bjos-8641016	121	3	m	m	PROPN
bjos-8641016	121	4	,	,	PUNCT
bjos-8641016	121	5	pawlowski	pawlowski	VERB
bjos-8641016	121	6	j	j	PROPN
bjos-8641016	121	7	,	,	PUNCT
bjos-8641016	121	8	hilgert	hilgert	PROPN
bjos-8641016	121	9	j	j	PROPN
bjos-8641016	121	10	b	b	PROPN
bjos-8641016	121	11	,	,	PUNCT
bjos-8641016	121	12	hugo	hugo	PROPN
bjos-8641016	121	13	fn	fn	PROPN
bjos-8641016	121	14	,	,	PUNCT
bjos-8641016	121	15	bandeira	bandeira	PROPN
bjos-8641016	121	16	d	d	PROPN
bjos-8641016	121	17	,	,	PUNCT
bjos-8641016	121	18	lhüller	lhüller	PROPN
bjos-8641016	121	19	f	f	PROPN
bjos-8641016	121	20	,	,	PUNCT
bjos-8641016	121	21	et	et	PROPN
bjos-8641016	121	22	al	al	PROPN
bjos-8641016	121	23	.	.	PUNCT
bjos-8641016	121	24	anxiety	anxiety	NOUN
bjos-8641016	121	25	and	and	CCONJ
bjos-8641016	121	26	salivary	salivary	ADJ
bjos-8641016	121	27	cortisol	cortisol	ADJ
bjos-8641016	121	28	levels	level	NOUN
bjos-8641016	121	29	in	in	ADP
bjos-8641016	121	30	patients	patient	NOUN
bjos-8641016	121	31	with	with	ADP
bjos-8641016	121	32	burning	burn	VERB
bjos-8641016	121	33	mouth	mouth	NOUN
bjos-8641016	121	34	syndrome	syndrome	NOUN
bjos-8641016	121	35	:	:	PUNCT
bjos-8641016	121	36	case	case	NOUN
bjos-8641016	121	37	-	-	PUNCT
bjos-8641016	121	38	control	control	NOUN
bjos-8641016	121	39	study	study	NOUN
bjos-8641016	121	40	.	.	PUNCT
bjos-8641016	122	1	oral	oral	ADJ
bjos-8641016	122	2	surg	surg	NOUN
bjos-8641016	122	3	oral	oral	ADJ
bjos-8641016	122	4	med	med	ADJ
bjos-8641016	122	5	oral	oral	ADJ
bjos-8641016	122	6	pathol	pathol	NOUN
bjos-8641016	122	7	oral	oral	ADJ
bjos-8641016	122	8	radiol	radiol	NOUN
bjos-8641016	122	9	endod	endod	PROPN
bjos-8641016	122	10	.	.	PUNCT
bjos-8641016	122	11	2008	2008	NUM
bjos-8641016	122	12	;	;	PUNCT
bjos-8641016	122	13	105	105	NUM
bjos-8641016	122	14	:	:	PUNCT
bjos-8641016	122	15	460	460	NUM
bjos-8641016	122	16	-	-	SYM
bjos-8641016	122	17	5	5	NUM
bjos-8641016	122	18	.	.	NOUN
bjos-8641016	122	19	11	11	NUM
bjos-8641016	122	20	.	.	PUNCT
bjos-8641016	123	1	van	van	PROPN
bjos-8641016	123	2	den	den	PROPN
bjos-8641016	123	3	berg	berg	PROPN
bjos-8641016	123	4	i	i	PROPN
bjos-8641016	123	5	,	,	PUNCT
bjos-8641016	123	6	pijpe	pijpe	PROPN
bjos-8641016	123	7	j	j	PROPN
bjos-8641016	123	8	,	,	PUNCT
bjos-8641016	123	9	vissink	vissink	PROPN
bjos-8641016	123	10	a.	a.	NOUN
bjos-8641016	123	11	salivary	salivary	PROPN
bjos-8641016	123	12	gland	gland	NOUN
bjos-8641016	123	13	parameters	parameter	NOUN
bjos-8641016	123	14	and	and	CCONJ
bjos-8641016	123	15	clinical	clinical	ADJ
bjos-8641016	123	16	data	datum	NOUN
bjos-8641016	123	17	related	relate	VERB
bjos-8641016	123	18	to	to	ADP
bjos-8641016	123	19	the	the	DET
bjos-8641016	123	20	underlying	underlie	VERB
bjos-8641016	123	21	disorder	disorder	NOUN
bjos-8641016	123	22	in	in	ADP
bjos-8641016	123	23	patients	patient	NOUN
bjos-8641016	123	24	with	with	ADP
bjos-8641016	123	25	persisting	persist	VERB
bjos-8641016	123	26	xerostomia	xerostomia	NOUN
bjos-8641016	123	27	.	.	PUNCT
bjos-8641016	124	1	eur	eur	PROPN
bjos-8641016	124	2	j	j	PROPN
bjos-8641016	124	3	oral	oral	PROPN
bjos-8641016	124	4	sci	sci	PROPN
bjos-8641016	124	5	.	.	PROPN
bjos-8641016	124	6	2007	2007	NUM
bjos-8641016	124	7	;	;	PUNCT
bjos-8641016	124	8	115	115	NUM
bjos-8641016	124	9	:	:	PUNCT
bjos-8641016	124	10	97	97	NUM
bjos-8641016	124	11	-	-	SYM
bjos-8641016	124	12	102	102	NUM
bjos-8641016	124	13	.	.	PUNCT
bjos-8641016	124	14	12	12	NUM
bjos-8641016	124	15	.	.	PUNCT
bjos-8641016	124	16	rosário	rosário	PROPN
bjos-8641016	124	17	pws	pws	PROPN
bjos-8641016	124	18	,	,	PUNCT
bjos-8641016	124	19	maia	maia	PROPN
bjos-8641016	124	20	ffr	ffr	PROPN
bjos-8641016	124	21	,	,	PUNCT
bjos-8641016	124	22	barroso	barroso	PROPN
bjos-8641016	124	23	a	a	PROPN
bjos-8641016	124	24	,	,	PUNCT
bjos-8641016	124	25	padrão	padrão	PROPN
bjos-8641016	124	26	el	el	PROPN
bjos-8641016	124	27	,	,	PUNCT
bjos-8641016	124	28	rezende	rezende	PROPN
bjos-8641016	124	29	l	l	PROPN
bjos-8641016	124	30	,	,	PUNCT
bjos-8641016	124	31	purish	purish	PROPN
bjos-8641016	124	32	s.	s.	PROPN
bjos-8641016	124	33	sialoadenitis	sialoadenitis	PROPN
bjos-8641016	124	34	following	follow	VERB
bjos-8641016	124	35	ablative	ablative	ADJ
bjos-8641016	124	36	therapy	therapy	NOUN
bjos-8641016	124	37	with	with	ADP
bjos-8641016	124	38	high	high	ADJ
bjos-8641016	124	39	doses	dose	NOUN
bjos-8641016	124	40	of	of	ADP
bjos-8641016	124	41	radioiodine	radioiodine	NOUN
bjos-8641016	124	42	for	for	ADP
bjos-8641016	124	43	treatment	treatment	NOUN
bjos-8641016	124	44	of	of	ADP
bjos-8641016	124	45	differentiated	differentiated	ADJ
bjos-8641016	124	46	thyroid	thyroid	NOUN
bjos-8641016	124	47	cancer	cancer	NOUN
bjos-8641016	124	48	.	.	PUNCT
bjos-8641016	125	1	arq	arq	PROPN
bjos-8641016	125	2	bras	bras	PROPN
bjos-8641016	125	3	endocrinol	endocrinol	NOUN
bjos-8641016	125	4	metabol	metabol	NOUN
bjos-8641016	125	5	.	.	PUNCT
bjos-8641016	126	1	2004	2004	NUM
bjos-8641016	126	2	;	;	PUNCT
bjos-8641016	126	3	48	48	NUM
bjos-8641016	126	4	:	:	PUNCT
bjos-8641016	126	5	310	310	NUM
bjos-8641016	126	6	-	-	SYM
bjos-8641016	126	7	4	4	NUM
bjos-8641016	126	8	.	.	NOUN
bjos-8641016	126	9	13	13	NUM
bjos-8641016	126	10	.	.	PUNCT
bjos-8641016	126	11	rosário	rosário	PROPN
bjos-8641016	126	12	pws	pws	PROPN
bjos-8641016	126	13	,	,	PUNCT
bjos-8641016	126	14	cardoso	cardoso	PROPN
bjos-8641016	126	15	ld	ld	PROPN
bjos-8641016	126	16	,	,	PUNCT
bjos-8641016	126	17	barroso	barroso	PROPN
bjos-8641016	126	18	al	al	PROPN
bjos-8641016	126	19	,	,	PUNCT
bjos-8641016	126	20	padrão	padrão	PROPN
bjos-8641016	126	21	el	el	PROPN
bjos-8641016	126	22	,	,	PUNCT
bjos-8641016	126	23	rezende	rezende	PROPN
bjos-8641016	126	24	ll	ll	PROPN
bjos-8641016	126	25	,	,	PUNCT
bjos-8641016	126	26	purish	purish	PROPN
bjos-8641016	126	27	s.	s.	PROPN
bjos-8641016	126	28	safety	safety	PROPN
bjos-8641016	126	29	of	of	ADP
bjos-8641016	126	30	radioiodine	radioiodine	NOUN
bjos-8641016	126	31	therapy	therapy	NOUN
bjos-8641016	126	32	in	in	ADP
bjos-8641016	126	33	patients	patient	NOUN
bjos-8641016	126	34	with	with	ADP
bjos-8641016	126	35	thyroid	thyroid	NOUN
bjos-8641016	126	36	carcinoma	carcinoma	NOUN
bjos-8641016	126	37	younger	young	ADJ
bjos-8641016	126	38	than	than	ADP
bjos-8641016	126	39	21	21	NUM
bjos-8641016	126	40	years	year	NOUN
bjos-8641016	126	41	.	.	PUNCT
bjos-8641016	127	1	arq	arq	PROPN
bjos-8641016	127	2	bras	bras	PROPN
bjos-8641016	127	3	endocrinol	endocrinol	NOUN
bjos-8641016	127	4	metabol	metabol	NOUN
bjos-8641016	127	5	.	.	PUNCT
bjos-8641016	128	1	2005	2005	NUM
bjos-8641016	128	2	;	;	PUNCT
bjos-8641016	128	3	49	49	NUM
bjos-8641016	128	4	:	:	PUNCT
bjos-8641016	128	5	241	241	NUM
bjos-8641016	128	6	-	-	SYM
bjos-8641016	128	7	5	5	NUM
bjos-8641016	128	8	.	.	NOUN
bjos-8641016	128	9	14	14	NUM
bjos-8641016	128	10	.	.	PUNCT
bjos-8641016	129	1	caglar	caglar	PROPN
bjos-8641016	129	2	m	m	PROPN
bjos-8641016	129	3	,	,	PUNCT
bjos-8641016	129	4	tungel	tungel	PROPN
bjos-8641016	129	5	m	m	PROPN
bjos-8641016	129	6	,	,	PUNCT
bjos-8641016	129	7	alpar	alpar	PROPN
bjos-8641016	129	8	r.	r.	PROPN
bjos-8641016	129	9	scintigraphic	scintigraphic	PROPN
bjos-8641016	129	10	evaluation	evaluation	NOUN
bjos-8641016	129	11	of	of	ADP
bjos-8641016	129	12	salivary	salivary	ADJ
bjos-8641016	129	13	gland	gland	NOUN
bjos-8641016	129	14	dysfunction	dysfunction	NOUN
bjos-8641016	129	15	in	in	ADP
bjos-8641016	129	16	patients	patient	NOUN
bjos-8641016	129	17	with	with	ADP
bjos-8641016	129	18	thyroid	thyroid	NOUN
bjos-8641016	129	19	cancer	cancer	NOUN
bjos-8641016	129	20	after	after	ADP
bjos-8641016	129	21	radioiodine	radioiodine	NOUN
bjos-8641016	129	22	treatment	treatment	NOUN
bjos-8641016	129	23	.	.	PUNCT
bjos-8641016	130	1	clin	clin	PROPN
bjos-8641016	130	2	nucl	nucl	PROPN
bjos-8641016	130	3	med	med	PROPN
bjos-8641016	130	4	.	.	PROPN
bjos-8641016	130	5	2002	2002	NUM
bjos-8641016	130	6	;	;	PUNCT
bjos-8641016	130	7	27	27	NUM
bjos-8641016	130	8	:	:	PUNCT
bjos-8641016	130	9	767	767	NUM
bjos-8641016	130	10	-	-	SYM
bjos-8641016	130	11	71	71	NUM
bjos-8641016	130	12	.	.	PUNCT
bjos-8641016	131	1	15	15	NUM
bjos-8641016	131	2	.	.	PUNCT
bjos-8641016	132	1	van	van	PROPN
bjos-8641016	132	2	nostrand	nostrand	PROPN
bjos-8641016	132	3	d	d	PROPN
bjos-8641016	132	4	,	,	PUNCT
bjos-8641016	132	5	atkins	atkins	PROPN
bjos-8641016	132	6	f	f	PROPN
bjos-8641016	132	7	,	,	PUNCT
bjos-8641016	132	8	bandaru	bandaru	NOUN
bjos-8641016	132	9	vv	vv	PROPN
bjos-8641016	132	10	,	,	PUNCT
bjos-8641016	132	11	chennupati	chennupati	PROPN
bjos-8641016	132	12	sp	sp	PROPN
bjos-8641016	132	13	,	,	PUNCT
bjos-8641016	132	14	moreau	moreau	PROPN
bjos-8641016	132	15	s	s	PROPN
bjos-8641016	132	16	,	,	PUNCT
bjos-8641016	132	17	burman	burman	PROPN
bjos-8641016	132	18	k	k	PROPN
bjos-8641016	132	19	,	,	PUNCT
bjos-8641016	132	20	et	et	PROPN
bjos-8641016	132	21	al	al	PROPN
bjos-8641016	132	22	.	.	PROPN
bjos-8641016	133	1	salivary	salivary	PROPN
bjos-8641016	133	2	gland	gland	NOUN
bjos-8641016	133	3	protection	protection	NOUN
bjos-8641016	133	4	with	with	ADP
bjos-8641016	133	5	sialogogues	sialogogue	NOUN
bjos-8641016	133	6	:	:	PUNCT
bjos-8641016	133	7	a	a	DET
bjos-8641016	133	8	case	case	NOUN
bjos-8641016	133	9	study	study	NOUN
bjos-8641016	133	10	.	.	PUNCT
bjos-8641016	133	11	thyroid	thyroid	NOUN
bjos-8641016	133	12	.	.	PUNCT
bjos-8641016	134	1	2009	2009	NUM
bjos-8641016	134	2	;	;	PUNCT
bjos-8641016	134	3	19	19	NUM
bjos-8641016	134	4	:	:	SYM
bjos-8641016	134	5	1005	1005	NUM
bjos-8641016	134	6	-	-	SYM
bjos-8641016	134	7	8	8	NUM
bjos-8641016	134	8	.	.	NUM
bjos-8641016	134	9	16	16	NUM
bjos-8641016	134	10	.	.	PUNCT
bjos-8641016	135	1	bomeli	bomeli	PROPN
bjos-8641016	135	2	sr	sr	PROPN
bjos-8641016	135	3	,	,	PUNCT
bjos-8641016	135	4	desai	desai	PROPN
bjos-8641016	135	5	sc	sc	PROPN
bjos-8641016	135	6	,	,	PUNCT
bjos-8641016	135	7	johnson	johnson	PROPN
bjos-8641016	135	8	jt	jt	PROPN
bjos-8641016	135	9	,	,	PUNCT
bjos-8641016	135	10	walvekar	walvekar	PROPN
bjos-8641016	135	11	rr	rr	PROPN
bjos-8641016	135	12	.	.	PUNCT
bjos-8641016	136	1	management	management	NOUN
bjos-8641016	136	2	of	of	ADP
bjos-8641016	136	3	salivary	salivary	ADJ
bjos-8641016	136	4	flow	flow	NOUN
bjos-8641016	136	5	in	in	ADP
bjos-8641016	136	6	head	head	NOUN
bjos-8641016	136	7	and	and	CCONJ
bjos-8641016	136	8	neck	neck	NOUN
bjos-8641016	136	9	cancer	cancer	NOUN
bjos-8641016	136	10	patients	patient	NOUN
bjos-8641016	136	11	a	a	DET
bjos-8641016	136	12	systematic	systematic	ADJ
bjos-8641016	136	13	review	review	NOUN
bjos-8641016	136	14	.	.	PUNCT
bjos-8641016	137	1	oral	oral	ADJ
bjos-8641016	137	2	oncol	oncol	ADJ
bjos-8641016	137	3	.	.	PUNCT
bjos-8641016	138	1	2008	2008	NUM
bjos-8641016	138	2	;	;	PUNCT
bjos-8641016	139	1	44	44	NUM
bjos-8641016	139	2	:	:	SYM
bjos-8641016	139	3	1000	1000	NUM
bjos-8641016	139	4	-	-	SYM
bjos-8641016	139	5	8	8	NUM
bjos-8641016	139	6	.	.	PUNCT
bjos-8641016	139	7	profile	profile	NOUN
bjos-8641016	139	8	of	of	ADP
bjos-8641016	139	9	salivary	salivary	ADJ
bjos-8641016	139	10	gland	gland	NOUN
bjos-8641016	139	11	flow	flow	NOUN
bjos-8641016	139	12	dysfunctions	dysfunction	NOUN
bjos-8641016	139	13	in	in	ADP
bjos-8641016	139	14	patients	patient	NOUN
bjos-8641016	139	15	with	with	ADP
bjos-8641016	139	16	differentiated	differentiated	ADJ
bjos-8641016	139	17	thyroid	thyroid	NOUN
bjos-8641016	139	18	carcinoma	carcinoma	NOUN
bjos-8641016	139	19	submitted	submit	VERB
bjos-8641016	139	20	to	to	PART
bjos-8641016	139	21	radioiodine	radioiodine	VERB
bjos-8641016	139	22	therapy	therapy	NOUN
bjos-8641016	139	23	braz	braz	PROPN
bjos-8641016	139	24	j	j	PROPN
bjos-8641016	139	25	oral	oral	PROPN
bjos-8641016	139	26	sci	sci	PROPN
bjos-8641016	139	27	.	.	PUNCT
bjos-8641016	140	1	12(3):169	12(3):169	NUM
bjos-8641016	140	2	-	-	SYM
bjos-8641016	140	3	172	172	NUM